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Abstract 
Laboratory rodents are widely used in a variety of experimental techniques 
throughout the world, which helps in advancing biomedical research. As this use is likely to 
continue in the future, it is imperative to prioritize animal welfare so that this research 
meets ethical standards, facilitates better science and increases the reproducibility of data.  
Laboratory rodents are regularly anaesthetised as part of biomedical research 
throughout the world. An anaesthetic agent that is predictable, safe and efficient enough to 
alleviate pain and distress throughout the duration of anaesthesia is considered ideal. 
Although there is no ideal anaesthetic available, a constant search for improving current 
anaesthetic strategies is important. Alfaxalone is a neuroactive steroid available as an 
injectable anaesthetic and used in large animals such as dogs, cats, horses and swine 
with safety. However, it often exhibits a significant motor excitation in the form of limb 
paddling and facial twitching when used in laboratory rodents. We sought to investigate if 
alfaxalone modulates synaptic neurotransmission to central motor neurons and if there are 
any underlying second messenger systems that are triggered leading to excitatory 
behaviour upon alfaxalone administration.  
We investigated the effects of alfaxalone on inhibitory glycinergic and excitatory 
glutamatergic synaptic transmission to rat hypoglossal motor neurons (HMNs). Whole-cell 
patch clamp recordings were made from neonatal (P7-14) rat HMNs within the hypoglossal 
nucleus in a 300µm thick transverse brainstem slice. Spontaneous or evoked excitatory 
post-synaptic currents (sEPSCs/eEPSCs) or miniature glycinergic inhibitory post-synaptic 
currents (mIPSCs) were recorded at a holding potential of -60mV using a CsCl-based 
internal solution. Similarly, action potential (AP) firing was recorded at a holding potential 
of -65mV with a K+ methyl sulfate-based internal solution. Our results show that alfaxalone 
significantly reduced mIPSC frequency (-39%) and amplitude (-54%) to HMNs, consistent 
with a reduction in inhibitory transmission to HMNs, possibly leading to neuromotor 
excitation exhibited as muscle twitching. There was also a positive shift (+35%) in the 
baseline holding current (Iholding) upon alfaxalone treatment. It was also noted that 
alfaxalone, even at higher concentrations (10nM-3µM), failed to significantly alter either 
spontaneous or evoked (25µM) EPSC frequency, amplitude, half-width, rise-time and 
Iholding. Similarly, repetitive action potential firing by HMNs was not altered by alfaxalone. 
However, the molecular mechanism behind the effect of alfaxalone in inhibiting glycinergic 
transmission remains unclear.  
Earlier reports have suggested that steroids and steroid-like molecules can bring 
about modulation of several TRP channels, which may be physiologically significant. Our 
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data showed a shift in Iholding upon alfaxalone treatment, which could be due to an indirect 
modulation of transient receptor potential (TRP) channels. Hence, to investigate this 
further, the effects of capsaicin, a well-known TRPV1 agonist, on synaptic transmission to 
HMNs was examined. Interestingly, we found that capsaicin increased spontaneous 
excitatory post-synaptic current (sEPSC) frequency (+115%) and amplitude (+24%) 
recorded from neonatal rat HMNs. The frequency of miniature excitatory post-synaptic 
currents (mEPSCs), recorded in the presence of tetrodotoxin (TTX), was also increased by 
capsaicin, but capsaicin did not alter mEPSC amplitude, consistent with a pre-synaptic 
mechanism of action. A negative shift in Iholding was elicited by capsaicin under both 
recording conditions. The effect of capsaicin on excitatory synaptic transmission remained 
unchanged in the presence of the TRPV1 antagonists, capsazepine or SB366791, 
suggesting that capsaicin acts via a mechanism which does not require TRPV1 activation. 
Capsaicin, however, failed to show any effect on eEPSCs, and did not alter the paired-
pulse ratio (PPR) of eEPSCs. Repetitive action potential (AP) firing in HMNs was also 
unaltered by capsaicin, indicating that capsaicin does not change intrinsic HMN 
excitability. Interestingly, the effect of capsaicin on spontaneous and miniature glycinergic 
inhibitory post-synaptic currents (sIPSC/mIPSC) was a significant decrease in current 
amplitude (-62% and 56% respectively) without altering frequency, indicating a post-
synaptic mechanism of action. Interestingly, even this effect of capsaicin on inhibitory 
current amplitude was not blocked by TRPV1 antagonist, capsazepine. These results 
suggest that modulation of IPSCs by neuroactive steroid, alfaxalone, is unlikely to involve 
TRPV1 activation.  
Our results indicate that neuromotor excitation during alfaxalone anaesthesia are 
most likely to be mediated by decreases in inhibitory synaptic input, without alteration in 
spontaneous or evoked excitatory synaptic transmission, and that alfaxalone does not 
excite HMNs sufficiently to cause any changes in action potential firing. We also 
demonstrate that capsaicin exerts a modulatory effect on glutamatergic excitatory as well 
as glycinergic inhibitory, synaptic transmission in HMNs via an unknown mechanism 
independent of TRPV1 channels. 
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Chapter 1 
Introduction 
Laboratory animals in biomedical research 
Use of animals in laboratories is an integral part of biomedical research. Animal 
experiments not only help us to understand physiology better, but also help in 
understanding the changes that occur between normal and diseased states. Animal 
experiments help in understanding a clinical disease better, and hence, propel the 
discovery of suitable targets to influence the pathophysiological causes of disease. Use of 
animals in laboratories has led to improvement of the lives of humans and domestic 
animals to a great extent, by reducing suffering and promoting health across the world.  
In the 20th century, with the development of biomedical disciplines such as 
pharmacology, toxicology and immunology, there has been a sharp increase in the use of 
animals for research purposes (Baumans, 2004). Among the various animals used in 
research, laboratory rodents (rats and mice) are the most widely used experimental 
species. They are routinely used in a variety of research experiments; from fundamental 
biological research to cardiovascular, neurological, and neurobehavioural studies, 
laboratory rodents have helped in advancing all key areas of biomedical research. The 
laboratory rat (Rattus norvegicus), in particular, is a unique model to understand human 
diseases better, allowing testing of novel therapeutic agents in efficient ways. Traditionally, 
toxicological studies have also relied more on rats than on mice. Also, when it comes to 
physiological manipulations, rats are preferred over mice, owing to their larger body size 
(Krinke, 2000). The prominent importance of rats in research can be easily gauged from 
the fact that they are the most widely used species in research after humans; no other 
model system is as widely used as are rats, followed by mice (Jacob, 2010).  
With the increasing use of laboratory rodents likely to continue in the foreseeable 
future, it is also equally important to take care of their welfare in order to facilitate better 
science and ensure the reproducibility of data. With the landmark publication of The 
Principles of Humane Experimental Technique in 1959 by William Russell and Rex Burch, 
it was made clear that humane techniques like the 3 R principles of replacement, reduction, 
and refinement are prerequisites for successful animal experiments (Hubrecht & Kirkwood, 
2010). Since then, researchers all over the world follow the 3 R principles.    
Laboratory animal anaesthesia 
One of the key pillars of the 3 R principles is that of refinement, which refers to 
implementation of modified experimental procedures to minimize suffering, pain and 
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distress to animals (Aronson, 1990). An effective way to minimize pain and suffering in 
laboratory rodents is by the use of suitable anaesthesia for all procedures likely to cause 
significant pain. Anaesthesia in laboratory animals can be defined as a state of loss of 
consciousness and sensation with muscle relaxation (Kohn et al., 1997). Anaesthesia is an 
important means by which the experimenter makes sure that distress is minimized in 
animals. In addition to this, research experiments frequently demand either a short duration 
of immobilization (e.g. retro-orbital blood collection) or prolonged immobilization with 
sufficient muscle relaxation (e.g. survival surgeries) for which the animal has to be 
anaesthetised. Critical surgical procedures can only be performed with ease if rodents are 
successfully subjected to a controlled, deep and relaxed state of anaesthesia for the 
duration of surgery. Thus, the continued use of animals in biomedical research brings an 
imperative need to develop a safe anaesthetic protocol.  
Anaesthetic regimes currently used in common laboratory practices make use of 
agents that typically fall under two categories, based on their route of administration viz. 
inhalation and injectable anaesthesia. Inhalation anaesthetics are generally gases or 
volatile liquids and the popular choices include halothane, isoflurane, sevoflurane, etc. 
However, the natural state of these agents makes it necessary to use specialized 
machines or vaporizers that mixes oxygen with the vaporized anaesthetic and delivers this 
mixture to the animal. Inhalation anaesthesia involves special instruments making the 
overall setup expensive, and generally requires specialized training, which makes it less 
suitable for regular use in standard laboratory settings, making it less preferable. On the 
other hand, injectable anaesthetics are those that can be easily administered by injection 
of the anaesthetic agents. The most prominent advantage of injectable anaesthetics over 
inhalation anaesthetics is convenience, particularly for personnel who can perform 
injections with little professional training. They also do not require any special set up; 
making it the least expensive mode of anaesthesia. Also, most small laboratory rodents 
can be humanely restrained for anaesthetic injections either via intraperitoneal (IP) or 
intramuscular (IM) routes, provided they are accustomed to being handled. Intravenous 
(IV) injections are sometimes difficult in these small species, and hence, administration via 
intraperitoneal, subcutaneous (SC) or intramuscular routes is usually preferred (Flecknell, 
1993; Flecknell, 2016b). Additionally, administration via intraperitoneal and subcutaneous 
routes is also considered less stressful to the animals as it causes less pain and damage. 
In general, IP injections are usually preferred because they need very little training and 
require minimum equipment. Although injectable anaesthesia is relatively simple, there is 
always a risk when a single bolus preparation is administered, as adjustment of dose is not 
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possible, except for topping up. Considering this, it is empirical to develop injectable 
anaesthetic agents that are reliable with a high margin of safety. The current popular 
injectable anaesthetic medications for laboratory rodents include pentobarbital, morphine, 
fentanyl, naloxone, or a combination of ketamine with xylazine or acepromazine or 
diazepam or midazolam, etc. The ease and minimal cost associated with injectable 
anaesthetics make them an agent of choice for anaesthesia in laboratory animals 
worldwide. However, this current range of anaesthetic agents is fairly limited and not all 
agents can be safely used in regular laboratory practices without any unwanted side 
effects.  
Safety in laboratory rodent anaesthesia 
The most critical part of development of any anaesthetic formulation is safety. 
Safety is usually assessed by a therapeutic window, which compares the amount of drug 
required for a therapeutic effect to the amount that causes toxicity. Early anaesthetic 
agents like chloroform and ether had a lower therapeutic window when compared to 
modern anaesthetics like fentanyl and ketamine (Stanley, 2000). The ability to monitor vital 
signs during anaesthesia and use of combinations of anaesthetics as opposed to single 
agents has also significantly increased the safety of anaesthesia in laboratory settings. As 
monitoring of vital signs usually employs specialized equipment to be handled by 
professionals, it is not the most desired method for laboratory rodent anaesthesia. Hence, 
in regular laboratory practices, a formulation with an improved therapeutic window, which 
is predictable and easy to administer, is desired.  
Limitations of current anaesthetic regimes 
Anaesthetic agents currently used in common laboratory practices to induce 
general anaesthesia are not free of adverse events and often show significant side effects, 
like respiratory and cardiovascular system depression. However, if these events do not 
interfere sufficiently with the normal physiology of animals, the use of the anaesthetic 
agent is considered acceptable. Use of a combination of anaesthetic agents or application 
of premedication, can sometimes decrease these unwanted events, but usually fails to 
make anaesthesia completely free of side effects. Reports have suggested potential 
alteration in the normal physiology of animals following anaesthesia, like post-operative 
cognitive dysfunction (POCD), altered immune response and other functional impairments, 
thereby adversely affecting the post-operative outcome. For example, one of the most 
popular anaesthetic combinations, ketamine-xylazine, which is considered to be the first 
choice for injectable rodent anaesthesia, has a major drawback when administered by 
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intramuscular route in rats, as it causes muscle necrosis (Smiler et al., 1990; Wellington et 
al., 2013) and ketamine at its anaesthetic dose also shows prolonged antidepressant 
effects (Yilmaz et al., 2002), which is a major limitation especially when collection of 
behavioural data is planned. Ketamine also causes long-lasting cognitive deficits in young 
rhesus monkeys (Paule et al., 2011), thus questioning its wide spread use in laboratory 
research. Also, many of the commonly used anaesthetics like tribromoethanol, chloral 
hydrate, pentobarbital, and urethane affect the basal immune status of rats (Bette et al., 
2004). In addition to this, studies also indicate that neuronal apoptosis is particularly 
increased during the developmental phase of the fetal rodent brain upon exposure to these 
agents (Loepke & Soriano, 2008; Istaphanous & Loepke, 2009). Similarly, inhalation 
anaesthetics, which are successfully used in many anaesthetic protocols, are known to 
cause dose-dependent respiratory depression and increased oligomerization of A-beta 
(Aβ) peptide that is considered as an early stage of Alzheimer’s dementia (Eckenhoff et 
al., 2004).  
These observations make it evident that most anaesthetics cause long-term 
impairment of brain function and hence can adversely affect the post-surgical outcome, 
thereby compromising the quality of scientific data. The lack of a suitable anaesthetic 
protocol was further emphasized when Lau and colleagues conducted a laboratory rodent 
anaesthetic survey, which identified inadequate depth of anaesthesia to be the most 
common anaesthetic complication followed by unexpected anaesthetic wake-up, sharp 
drop in body temperature and apnoea. The survey also found a significant rate of mortality 
in rodents after the use of popular anaesthetics (Lau, 2013). These findings, along with 
other reports (Zuurbier et al., 2014; Flecknell, 2016a), clearly show that, although we have 
come a long way from the earlier anaesthetics like chloroform and ether, modern agents of 
anaesthesia are not free of unwanted side effects. Clearly, there is an urgent need to 
improve our understanding of various anaesthetic regimes and to explore the untapped 
potential of novel, as well as already existing, anaesthetic protocols so that laboratory 
rodents can be subjected to anaesthesia that is safe, predictable and relatively free of 
adverse events, ensuring the quality of scientific data collected. 
Current approaches to anaesthetic drug development 
The field of anaesthetic drug development largely relies on modification of chemical 
structures of already existing anaesthetic agents to enhance their pharmacokinetic and 
pharmacodynamic profiles. For example, analogues of drugs like midazolam, propofol and 
etomidate are under investigation to obtain a better anaesthetic agent, using similar 
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approachs (Chitilian et al., 2013). However, this traditional approach to drug discovery and 
development is highly expensive and time consuming. The other approach towards 
development of better anaesthetic regime is the improvement of current anaesthetic 
agents in order to get a better anaesthesia outcome. This approach can be undertaken by 
choosing a suitable combination of agents or by use of specific premedications to enhance 
or block a particular pharmacological pathway to abolish side effects. In this project, our 
approach has particularly focused on understanding the mechanism by which alfaxalone 
leads to neuromotor excitation, knowledge which will then enable us to rationally modify an 
already existing steroid based anaesthetic regime, in order to provide a safe and reliable 
anaesthetic formulation.  
Neurosteroids as anaesthetics 
Steroid molecules synthesized within the central nervous system (CNS) that 
modulate neuronal excitability by rapid non-genomic actions are called neurosteroids 
(Reddy, 2010). Neurosteroids are known to have organizational as well as activational 
roles in the CNS (Brinton, 2013). The pharmacological action of neurosteroids and/or their 
metabolites (including synthetic compounds) occur largely as a result of allosteric 
potentiation of the ionotropic ligand-gated ion channel gamma (γ) aminobutyric acid type A 
receptors (GABAA). Neurosteroids have been long-standing candidates known for their 
involvement in various conditions such as epilepsy, anxiety and depression (Reddy, 2010). 
Apart from their implication in various psychiatric conditions, certain endogenous steroid 
molecules like progesterone and testosterone, as well as synthetic neuroactive steroids, 
such as alfaxalone, show anaesthetic effects via their action on the GABAA receptor 
complex (Selye, 1941; Atkinson et al., 1965; Harrison & Simmonds, 1984; Harrison et al., 
1987; Reddy & Apanites, 2005). The anaesthetic properties of neurosteroids and its 
analogs should not come as a surprise, considering their strong modulatory effect on 
GABAA receptors to rapidly decrease neuronal excitability (Harrison et al., 1987), which are 
considered to be a leading candidate for the primary target of general anaesthetics (Arhem 
et al., 2003; Garcia et al., 2010; Son, 2010).  
The initial observations that steroid based molecules have very good anaesthetic 
properties were made by Hans Selye (1941), where he reported the hormone 
progesterone’s anaesthetic activity, but it was not until 1955, when Laubach and 
colleagues studied a series of steroids for their anaesthetic property and claimed 
hydroxydione (21-Hydroxypregnane-3, 20-dione sodium succinate) as the most promising 
water-soluble anaesthetic steroid (Laubach et al., 1955), that a renewed interest in the 
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anaesthetic properties of steroids was generated. The study showing the anaesthetic 
property of hydroxydione was particularly important, as it concluded hydroxydione to be 
superior to barbiturate anaesthesia, owing to minimal respiratory and cardiac depression; 
and gives a high ratio between toxicity in animals to that of safety in humans, providing a 
wide margin of safety (P'An et al., 1955). However, due to its slow onset of action and high 
tendency to produce phlebitis (venous irritation), use of hydroxydione had to be 
discontinued (Soliman & Brindle, 1976). The study of structural activity relationships also 
showed that water-soluble derivatives of steroidal anaesthetics were usually less active 
and slower-acting (Phillipps, 1975). This led to the development of Althesin in the early 
1970s, a water-insoluble combination of two different neurosteroids (viz. alfaxalone and 
alphadolone) that was devoid of the side effects seen in hydroxydione anaesthesia, while 
retaining minimal cardiorespiratory depression and wide margin of safety. Alphadolone, 
although being only half as potent when compared to alfaxalone, was a necessary 
component of the formulation as it increased the solubility of the formulation when 
dissolved in Cremophor EL (Swerdlow, 1973). This formulation of alfaxalone in 
combination with alphadolone was also used with great success as an anaesthetic agent 
(Saffan) for cats and dogs (Child et al., 1971; Child et al., 1972; Bomzon, 1981; Sear, 
1996) and was considered to have bridged the void in anaesthetic formulations available 
then (Morgan & Whitwam, 1985). Even though this combination had desirable anaesthetic 
properties, it also caused significant side effects and both Althesin and Saffan were later 
withdrawn from use in many countries. Limitations such as edema, coughing, partial 
laryngeal spasm, cyanosis and postoperative vomiting in cats (Dodman, 1980) and 
although less fatal, a high incidence of anaphylactoid reactions in dogs were observed 
(Warne et al., 2015). However, these unwanted side effects of hypersensitivity reactions 
associated with this combination were a result of the use of Cremophor EL, a non-ionic 
solubilizing agent which is polyethoxylated castor oil, and not the actual neurosteroids 
(Moneret-Vautrin et al., 1983). Later on, solubilizing alfaxalone in a biologically acceptable 
formulation was achieved by the use of cyclodextrins, which are widely used as 
solubilizing and stabilizing agents (Stella & He, 2008). This resulted in the current 
formulation of alfaxalone, Alfaxan CD, containing alfaxalone alone solubilized using a 
modified cyclodextrin called 2-hydroxypropyl-β-cyclodextrin (HPCD), which is used in 
veterinary anaesthesia in cats and dogs (Muir et al., 2008; Muir et al., 2009; Zaki et al., 
2009).  
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Alfaxalone 
 
 
Figure 1. Chemical structure of alfaxalone (3α-hydroxy-5α-pregnane-11, 20-dione) 
(image by Bryan Derksen via Wikimedia Commons). 
 
Among the various neuroactive steroids with anaesthetic properties, one that 
deserves a special mention is alfaxalone, as it has significant advantage over other 
agents. A high margin of safety has already been established for alfaxalone in veterinary 
anaesthesia (Davis & Pearce, 1972). The safety of its earlier formulation i.e. alfaxalone-
alphadolone has shown superiority over thiopentone, methohexitone, propanidid and 
ketamine for continuous administration and was considered to be excellent for short as 
well as long periods of anaesthesia (Green et al., 1978). Alfaxalone, by the virtue of being 
an analogue of allopregnanolone, is deemed to be neuroprotective as it suppresses 
central nervous system activity by acting as a potent modulator of GABAA receptor system 
and reducing excitotoxicity (Lambert et al., 1995; Yawno et al., 2009) and hence, use of an 
alfaxalone based anaesthetic regime seems to be the obvious step forward. At a cellular 
level, alfaxalone like other anaesthetic molecules depresses the activity of central neurons 
by enhancing GABA receptor activity in cultured spinal neurons (Barker et al., 1987). In 
addition to this, at higher concentrations of alfaxalone (comparable to clinical anaesthesia), 
enhanced membrane Cl- conductance was reported, which is associated with decrease in 
action potential generation probability, thereby attributing to its depressant action on brain 
(Barker et al., 1987). Similarly, alfaxalone also potentiates GABA induced currents in 
cultured cortical neurons (Sasa et al., 1996).  
However, studies have reported that alfaxalone (as Alfaxan CD) has a major 
drawback for laboratory rodent anaesthesia, that of prominent neuromotor excitation (Lau, 
2013; Siriarchavatana et al., 2016). Rats and mice show neuromotor excitation during the 
induction and recovery phase of anaesthesia. This excitation is particularly seen as 
twitching and limb paddling. Muscle twitches are also reported in cats (Mathis et al., 2012), 
pigs (Keates, 2003) and dogs (Ferre et al., 2006) after alfaxalone anaesthesia. Although 
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regular, these side effects are clinically insignificant in dogs and cats (Jurox, 2011) and 
hence, the use of the current alfaxalone formulation is still continued.  
In rats, severe facial and whole body twitches were reported during induction and 
recovery phases of anaesthesia (Lau, 2013). This phenomenon was also reported in mice 
earlier when older formulation, Saffan (alphaxalone and alphadalone) was used (File & 
Simmonds, 1988) and later when improved formulation (alfaxalone alone encased in 
hydroxypropyl-β-cyclodextrin) was used (Siriarchavatana et al., 2016). These neuro-
excitatory effects are the major barrier in developing an effective alfaxalone based 
anaesthetic regime for laboratory rodents. Despite the potential importance of alfaxalone 
as an important anaesthetic agent in small laboratory rodents, little is understood about the 
molecular mechanisms that mediate this neuroexcitation. If the reasons for these 
neuromotor excitations can be established and then counteracted by pharmacological 
manipulation, alfaxalone is likely to become a valuable anaesthetic formulation for 
laboratory rodents. 
Neuromotor excitation during anaesthesia 
A close review of the literature suggests that neuro-excitatory motor responses, 
including limb rigidity and paddling, after induction of anaesthesia in dogs (Davies, 1991) 
and horses (Mama et al., 1995) have been observed with various anaesthetics. For 
example, excitation was observed with etomidate and propofol, which seemed to be due to 
enhanced spinal and brainstem activity shortly after induction of anaesthesia (Sneyd, 
1992). Although these events are rare and occasionally serious, recovery is usually 
classified as good or acceptable and there is no clinical complication seen post recovery, 
which is in stark contrast with the neuromotor twitching seen after alfaxalone anaesthesia 
in rats, where facial and whole body twitches are potentially severe and consistently 
observed and are seen as alfaxalone’s biggest shortcoming.  
Previous reports indicate that alfaxalone, particularly at high concentration 
potentiates the responses to glycine receptor activity, which could possibly contribute to 
the neuroexcitatory effects seen on alfaxalone anaesthesia. Lau and colleagues showed 
that inhibitory glycinergic neurotransmission to brainstem motor neurons is progressively 
suppressed by increasing alfaxalone concentration, potentially causing increased motor 
neuron excitability (Lau, 2013).  However, to date, no studies have examined the effects of 
alfaxalone on excitatory synaptic transmission to brainstem motor neurons, which will be a 
key point of investigation in exploring the neuro-excitation seen with alfaxalone 
anaesthesia. 
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Glutamatergic transmission in motor neurons 
Motor neurons in the brainstem and spinal cord are responsible for transforming 
central motor commands into a motor activity. The amino acid glutamate is a dominant 
excitatory neurotransmitter in the mammalian CNS (Collingridge & Lester, 1989; 
Nakanishi, 1992), and is also responsible for motor neuron excitability, thereby controlling 
involuntary and rhythmic movements. Glutamate receptors are also expressed on motor 
neurons, which are innervated by glutamatergic inputs from brain systems regulating the 
state of arousal and motor control (Rekling et al., 2000).  
Considering the importance of glutamatergic transmission in modulating motor 
neuron excitability, it becomes imperative to investigate the effect of alfaxalone on 
excitatory neurotransmission. Interestingly, prior study showed that alfaxalone potentiates 
synaptic transmission efficacy by enhancing release of excitatory transmitters, an effect 
associated with depression of excitability in a decerebrated cat preparation (Morris, 1978). 
A reduction in synaptic excitability after alfaxalone application was also reported in guinea 
pig cortical brain slice preparation (el-Beheiry & Puil, 1989). Alfaxalone also showed a 
depression in synaptic transmission as well as sensitivity of neurones to glutamate in 
guinea pig olfactory cortex (Richards & Smaje, 1976). These studies clearly indicate a 
possibility that neurosteroid alfaxalone can indeed change excitatory transmission and 
intrinsic excitability. However, to our knowledge no study until date has investigated a 
direct effect of alfaxalone application on excitatory transmission and intrinsic excitability in 
mammalian motor neurons. Therefore, evaluating the role of alfaxalone on glutamatergic 
excitatory neurotransmission in hypoglossal motor neurons might lead to key findings that 
can help in exploring targets for abolishing the neuro-excitatory twitching observed after 
alfaxalone anaesthesia. 
Possible involvement of transient receptor potential (TRP) channels in motor 
neuron excitation  
The transient receptor potential (TRP) channel family constitutes of 28 diverse 
mammalian members divided into 6 subfamilies based on amino acid sequence homology. 
The subfamilies include vanilloid (TRPV), melastatin (TRPM), canonical (TRPC), ankyrin 
(TRPA), mucolipin (TRPML), and polycystin (TRPP) (Benemei et al., 2015; Earley & 
Brayden, 2015) TRP channels. Multiple reports over the years have confirmed that TRP 
channels can influence cellular function in peripheral tissue as well as central neurons, by 
causing inward cation currents and directly affecting voltage gated ion channels, thereby 
bringing rapid changes in intracellular events ranging from contraction of smooth muscle to 
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neuronal depolarization (Nilius et al., 2007). 
TRP channels are widely expressed throughout the body and are activated by 
several endogenous and exogenous stimuli, which can be either chemical, physical or 
physiological in nature. For example, camphor and noxious hot temperatures can activate 
TRPV1 and TRPV3 (Selescu et al., 2013). TRPV1 can also be partially activated by 
voltage changes (Matta & Ahern, 2007). 2-aminoethoxydiphenyl borate (2-APB) and laser 
light of 640 nm, and light at 48 mW can activate TRPV2 (Hu et al., 2004; Zhang et al., 
2012). Similarly intracellular calcium is the physiological activator of TRPM5 channels 
(Prawitt et al., 2003) and ADP-ribose can activate TRPM2 (Rah et al., 2015). Arachidonic 
acid metabolite, 20-hydroxyeicosatetraenoic acid (20-HETE), is identified as activator of 
TRPC6 (Basora et al., 2003) and TRPA1 is activated by noxious cold temperatures (Story 
et al., 2003). 
Regulation of Ca2+ homeostasis is a critical determinant of several physiological 
functions like muscle contraction, integration of electrical signaling, neuronal excitability, 
etc. Under normal conditions, activation of TRP channels causes influx of both Na+ and 
Ca2+ ions, leading to increase in intracellular Ca2+ concentrations and thereby increasing 
excitability of cells. This further leads to a cascade of events, which can include activation 
of voltage sensitive Ca2+ channels and several other Na+ dependent processes (Estacion 
et al., 2006; Abramowitz & Birnbaumer, 2009; Birnbaumer, 2009).  
TRP channels are broadly considered as non-selective divalent cation channels as 
they all are more selective to conduct Ca2+ than other monovalent cations, which is largely 
responsible for their physiological roles (Clapham et al., 2001; Montell, 2001). An 
exception to this are TRPM4 and TRPM5, which are only permeable to monovalent 
cations (Nilius et al., 2005a). However, both channels are activated by a rise in internal 
Ca2+ and hence it plays a regulatory role in their activity. Their activation has reported to 
induce cell-membrane depolarization and activity of voltage gated ion channels which are 
strong determinants of cellular physiology (Guinamard et al., 2011).          
TRPM4 is a Ca2+ activated nonselective cation channel activated by an increase of 
intracellular Ca2+ and is regulated by several factors like temperature. Previous work has 
shown characteristic changes in inward current in hypoglossal motor neurons after 
application of increasing doses of alfaxalone where it induced an inward current, without a 
significant change in input resistance (Lau, 2013). 
The persistent inward current (PIC) has an important role to play in motor neuron 
firing. The characteristic prolonged firing observed in motor neurons even after cessation 
of input is attributed to the ability of the motoneuronal membrane to generate persistent 
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inward current (Elbasiouny et al., 2010). N- and P-type Ca2+ channels are the major 
contributors persistent current in juvenile HMNs, with little contribution from L-type Ca2+ 
channels and the persistent sodium current (Funk et al., 2011). However, another 
important contributor to PIC is a Ca2+ activated, non-selective cation conductance, that is 
believed to be mediated by the transient receptor potential melastatin 4 (TRPM4) channel 
(Nilius et al., 2005b; Funk et al., 2011).  
It is postulated that the inward shift in current by alfaxalone can be a possible 
reason for increased excitation in HMNs, which behaviourally manifests as muscle 
twitching. Also, the fact that these inward currents were blocked by 2-APB, a non-specific 
blocker of many TRP channels, emphasize the potential importance of TRP channels in 
causing an inward current and hence the prolonged firing in motor neurons after alfaxalone 
treatment. In order to identify the role of TRPM channels, in causing an inward shift in 
current and also to identify the specific channel involved, it is essential to investigate the 
effects of not only general, but also specific blockers of TRPM channels to see if excitatory 
effects of alfaxalone are mediated via TRPM channels. 
Rationale and aim of study 
Most or our understanding regarding the modulation of synaptic transmission to 
central neurons by steroid-based anaesthetic molecules is gathered by 
electrophysiological studies in brain slice preparations or in cultured neurons. However, all 
studies focused exclusively on the modulation of GABA receptor activity, as it is the 
primary target of most general anaesthetics. Alfaxalone, although modulates the activity of 
GABAA receptors, it is interesting to note that neuromuscular twitching is most prominently 
seen in laboratory rodents. Considering this, it is imperative to investigate further the 
modulation of alfaxalone induced changes in synaptic transmission. Lau and colleagues 
have provided our first understanding in this direction, by showing that alfaxalone does 
inhibit inhibitory glycinergic neurotransmission to rat hypoglossal motor neurons, which 
might be responsible for neuromuscular twitching seen upon alfaxalone anaesthesia in 
rats (Lau, 2013). Though this study did provide a starting point of investigation, the 
molecular mechanism behind this effect remains unidentified.  
The first aim of this study was to further investigate the effect of alfaxalone on 
miniature glycinergic inhibitory synaptic transmission; this was followed by evaluation of 
alfaxalone’s effects on excitatory glutamatergic transmission and then intrinsic excitability 
of HMNs in in vitro brain slices. The second aim was to investigate the cause of shift in 
membrane current after alfaxalone application and to check the possible involvement of 
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TRP channels in modulating motor neuron excitability. The final aim was to see if there is 
any species related difference between rats and mice in the effect of alfaxalone and TRP 
channel modulators on HMNs.  
 
Materials and methods 
Hypoglossal motor neurons (HMNs) to study effects of alfaxalone 
Motor neurons innervate the skeletal muscle system to evoke a motor response. To 
investigate if alfaxalone affects synaptic transmission to motor neurons, we used HMNs 
from acute rat brainstem slices. HMNs are specialized cranial MNs in the brainstem, 
responsible for various rhythmic motor activities like swallowing, sucking, speech, 
mastication, chewing and breathing (Berger et al., 1996; Peever & Duffin, 2001). HMNs 
show intricate dendritic arborizations that receive synaptic inputs from various brain 
regions, which provide a potential site for integration of various afferent inputs leading to 
modulation of their activity (Altschuler et al., 1994; Fukunishi et al., 1999; Tarras-Wahlberg 
& Rekling, 2009). HMNs soma and dendrites receive both glycinergic as well as 
GABAergic synaptic terminals (Aldes et al., 1988). Apart from this, the HMNs provide 
some unique features, which are valuable for examining the calcium dynamics. Firstly, 
HMNs exhibit lower endogenous calcium buffering capacity leading to an increased risk of 
Ca2+ mediated excitotoxicity (Lips & Keller, 1998). The second important feature of the 
HMN system is the strong inhibitory input that it receives from glycinergic inputs (Umemiya 
& Berger, 1995; Singer et al., 1998; Donato & Nistri, 2000; Singer & Berger, 2000). As the 
effect of alfaxalone has already been studied in detail for GABAergic inputs, we sought to 
examine its effects on the glycinergic system; as HMNs receive strong glycinergic inputs, it 
becomes a good model for our investigation. Moreover, a pilot study in our lab has already 
shown tongue twitching along with other behavioural outcomes like paw paddling and 
head bobbing upon alfaxalone anaesthesia in rats. This made HMNs an ideal model 
system to investigate the effects of alfaxalone in in-vitro preparations.  
 
Use of whole-cell patch-clamp technique 
Excitation during alfaxalone anaesthesia is an unwanted behavioural outcome 
which indicates significatant modulation of synaptic transmission in the brain. Patch-clamp 
electrophysiology in slice preparations is a reliable technique to measure inhibitory and 
excitatory synaptic currents in specific brain regions. This technique can also be employed 
in measurement of isolated ionic currents which are responsible for synaptic changes and 
to apply pharmacological agents in studying intracellular signalling pathways. More 
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importantly, this technique also allows for manipulation of voltage (to study voltage 
dependent ion channels) and current (to study action potential generation and intrinsic 
excitability) to provide mechanistic insights on the phenomenon of membrane excitability 
and synaptic transmission. Although slice electrophysiology is a low-throughput technique 
compared to others, it is still considered a gold standard for studying modulation of ion 
channels by drug candidates and is a vital tool for drug discovery (Fodor & Nagy, 2007).  
 
Brainstem slice preparation 
All experimental protocols were performed after approval from The University of 
Queensland Animal Ethics Committee (SBMS/142/15/NHMRC), and were in accordance 
with the Queensland Government Animal Research Act 2001, and associated Animal Care 
and Protection Regulations (2002 and 2008) as well as the Australian Code for the Care 
and Use of Animals for Scientific Purposes, 8th Edition (National Health and Medical 
Research Council, 2013). Either neonatal Wistar rats or C57Bl/6 mice (7-14 day old, either 
sex) were used for all experiments. This particular age of animals was selected because 
HMNs are electrically mature at this age and their soma is easily accessible for 
electrophysiological manipulation. Sodium pentobarbitone (Vetcare, Brisbane, Australia) at 
dose of 60-80mg/kg, was administered intraperitoneally to anaesthetize the animals, after 
which the skull was rapidly removed and entire brain was carefully dissected out (Fig. 2A). 
Further, the brainstem was isolated and placed in ice-cold high Mg2+-low Ca2+ artificial 
cerebrospinal fluid (aCSF), which contained (in mM) 130 NaCl, 26 NaHCO3, 3 KCl, 5 
MgCl2, 1 CaCl2, 1.25 NaH2PO4, 10 D-glucose (Bellingham & Berger, 1996). Care was 
taken to maintain aCSF at pH 7.4 by constantly bubbling with carbogen (95% O2 + 5% 
CO2). The rostral end of the brainstem was fixed on a metal chuck using cyanoacrylate 
glue. An agar block was glued to the chuck served as a support to the ventral surface of 
the brainstem (Fig. 2B). The metal chuck with tissue attached was submerged in ice-cold 
high Mg2+-low Ca2+ aCSF within a cutting chamber, and maintained ice-cold by a slurry of 
ice and water in a surrounding water bath. Using the central canal as a landmark, 
transverse brainstem slices (300µm thickness) were cut using a vibratome (Leica VT 
1200S, Leica Biosystems). An average of 3-4 slices containing hypoglossal motor nucleus 
were obtained from each animal. After cutting, slices were transferred to a holding 
chamber filled with high Mg2+-low Ca2+ aCSF at 37°C, in a temperature-controlled water 
bath for 45-60min. Finally, slices were transferred to a new holding chamber containing 
low Mg2+-high Ca2+ recording aCSF (1Mg2+-2Ca2+mM) and equilibrated for at least 30min 
before recording at room temperature (21-22°C).   
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Figure 2: Brainstem slices preparation. 
(A) Lateral orientation of brain showing 
the approximate location of hypoglossal 
nucleus (dotted circle). After isolation of 
brainstem, cyanoacrylate glue was used 
to fix the rostral end of brainstem to metal 
chuck. Using an agar block support was 
provided to the ventral surface (B). 
Horizontal lines denote the slicing plane. 
300µm thick transverse slices were cut, 
giving about 3-4 slices from each brain.   
 
Electrophysiology 
Individual slices were transferred to a recording chamber and continuously 
superfused (1-2ml/min) with low Mg2+-high Ca2+ aCSF throughout the experiment (Fig. 3). 
A custom-made harp was used to stabilize the slice in the chamber. The volume of the 
recording chamber was approximately 200µL. HMNs were individually identified using a 
60X water-immersion objective, an infrared video camera (Hamamatsu, Japan) and 
Nomarski optics on a Nikon E600FN microscope (Tokyo, Japan); all HMNs were ventral 
and lateral to the central canal, within the hypoglossal motor nucleus, and had a large 
soma. A quick assessment was made of the health of brainstem slices; slices with bright 
and shiny looking cells were considered healthy. However, slices with darker cells and 
visible nuclei were avoided. A Sony monitor was used to view neurons and recording 
electrode. Whole-cell patch-clamp recordings were made using an Axopatch 1D amplifier 
(Axon Instruments, Foster City, CA, USA). Synaptic current recordings were sampled at a 
rate of 10kHz, and low-pass filtered at 2kHz, while a higher sampling rate (50kHz) and 
low-pass filter (10kHz) settings were used for action potential recordings; data was 
sampled and stored on a Windows XP computer, using PClamp 10.2 software and a 
Digidata 1332A digitizer (Axon Instruments). The patch electrode was advanced to the cell 
surface using a micro-manipulator (MPC-200, Sutter Instrument Company). The electrode 
was directed to the cell body, so that electrode solution ejected by positive pressure 
produced a small dimple, showing that the electrode was touching the cell surface. 
Positive pressure was released and mild suction was applied until a stable membrane seal 
with resistance of >2GΩ was achieved. Stronger suction was then applied until the cell 
membrane was broken. Cells were voltage-clamped at membrane potentials of -60mV. At 
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least 5min were allowed for the cell to stabilize with the pipette internal solution before 
starting recordings.    
The patch pipette internal solution for recording excitatory and inhibitory post-
synaptic currents (EPSCs/IPSCs) contained (in mM) 120 CsCl, 4 NaCl, 4 MgCl2, 0.001 
CaCl2, 10 Cs N-2-hydroxyethyl-piperazine-N’-2-ethanesulfonic acid (HEPES), 10 caesium 
ethylene glycol-bis (β-aminoethyl ether)-N,N,N,N-tetra-acetic acid (EGTA), pH adjusted to 
7.2 with CsOH. The internal solution for recording action potentials contained (in mM) 135 
K methyl sulfate, 8 NaCl, 10 HEPES, and 0.3 EGTA; pH 7.2 with KOH. Pipette solution 
osmolarity was adjusted to 290-300mOsM with sucrose, using a vapour pressure 
osmometer (Wescor). Adenosine 5’-triphosphate (ATP-Mg) and 0.3 guanosine 5-
triphosphate-tris (hydroxymethyl) aminomethane (GTP-Tris) were added to the internal 
solution just before use. For recording glycinergic IPSCs, NBQX (10µM), APV (50µM) and 
bicuculline (5µM) were added to the recording buffer. Similarly, for recording glutamatergic 
EPSCs, strychnine HCl (20µM) was added to all external recording solutions to block both 
glycine and GABAA receptor-mediated inhibitory synaptic currents in HMNs. To isolate 
miniature synaptic currents, tetrodotoxin (TTX) at a final concentration of 1µM was added 
to the recording buffer. For evoked EPSC recordings, a bipolar concentric stimulation 
electrode (Frederick Haer) was placed in the reticular formation ventrolateral to the border 
of the hypoglossal nucleus, and a pair of stimulus currents of 0.5-1.1mA and 0.1ms 
duration was applied to reliably evoke an EPSC with consistent first pulse EPSC 
amplitudes; inter-stimulus interval was 150ms. Action potential (AP) firing was achieved by 
repetitive depolarizing current steps (2 to 120pA) of 400ms duration from a membrane 
potential of -65mV in current clamp mode. Input resistance was calculated from the steady 
state amplitude of a brief (40ms) negative (-10pA) current step prior to the depolarizing 
step. 
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Figure 3: Schematic representation (not to scale) of electrophysiology setup used in 
this study. 
This figure gives an overall view of key components involved in patch-clamp recordings 
from rodent brainstem slice preparations. In short, brain slices were placed in a tissue 
chamber (approximately 200µL volume), which had a continuous flow of recording buffer 
(aCSF) using a gravity fed perfusion system. A low power suction pump was used to drain 
out excess buffer from the tissue chamber. A micromanipulator was used to manoeuvre 
the recording glass pipette attached to an electrode holder, which was further connected to 
Axopatch 1D amplifier, digitizer and later to an oscilloscope and a computer running 
Windows XP software. Data acquisition was performed using PClamp software. When a 
stimulation electrode was used, another micromanipulator was installed to firmly hold the 
stimulation electrode on the opposite side to the recording electrode setup.  
 
Drug application 
All chemicals were procured from Sigma Aldrich (St Louis, MO, USA) except 
tetrodotoxin (TTX) which was obtained from Alomone Labs, Israel, and alfaxalone, which 
was a gift from Jurox Pty Ltd. The final concentrations of all drugs were prepared just 
before start of experiment. Alfaxalone was dissolved in hydroxypropyl substituted β-
cyclodextrin (HPCD, a gift of Jurox Pty Ltd) to a ratio of 1:8, capsaicin in ethanol, 
	
	
17 
capsazepine in methanol and SB366791 in DMSO to make stock solutions, which were 
then diluted using recording aCSF to final desired bath concentrations just before use.  
Drug concentrations for all drugs were chosen based on other comparable 
electrophysiological studies to make sure maximum drug induced responses are obtained. 
The reservoir containing SB366791 was always wrapped in aluminium foil to protect from 
light. Final concentration of all solvents was ≤ 0.25% in all experiments.  
 
Data Analysis  
Spontaneous and miniature synaptic currents were analysed from one or more files 
of 2min continuous data recordings (Fig. 4). Shape parameter (amplitude, 10-90% rise 
time, half-width) analysis was performed in Clampfit 10.2 (Axon Instruments), using a 
template created by averaging visually detected individual synaptic events. Baseline 
holding current (Iholding) and frequency of EPSCs for spontaneous recordings and input 
resistance for evoked recordings were also recorded. Paired-pulse ratio (PPR) was 
calculated as the mean peak amplitude of the averaged second evoked EPSC divided by 
the mean peak amplitude of the averaged first evoked EPSC. This data was imported into 
Excel (Microsoft) for further analysis. For action potential analysis, the effects of 
differences in resting membrane potential of individual HMNs were made relative to 
changing membrane threshold caused by depolarizing current steps in Clampfit. 
Results are expressed as mean ± S.D., unless otherwise stated, and a paired two-
tailed t-test was used to determine whether differences between data points under 
different conditions (control, drug, wash, etc.) was statistically significant at P<0.05, except 
where indicated, using Prism 7 (GraphPad). A two-sample Kolmogorov-Smirnov test was 
used to compare the cumulative frequency distributions of spontaneous and miniature 
synaptic currents.  
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Figure 4: Electrophysiology recordings and data analysis of synaptic currents and 
action potentials (APs) from hypoglossal motor neurons.  
Photograph of a typical brainstem slice containing the hypoglossal nucleus showing 
several hypoglossal motor neurons (A), identifiable by a large multipolar cell body. A 
recording electrode is shown approaching one of the motor neurons in the hypoglossal 
nucleus (B). (C) Shows a representative synaptic current trace recorded from a whole-cell 
patch clamp recording from a motor neuron. Negative going events were recorded from 
cells that were voltage-clamped at membrane potentials of -60 mV. Only distinct single 
currents (*) with a fast rising phase and a slower decay phase were selected for analysis 
of shape parameters. Example of an averaged current trace (D) showing sections used to 
calculate amplitude and half-width. Action potentials were evoked by injecting depolarizing 
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current steps from a membrane potential of -65 mV in current clamp mode. (E) Shows a 
typical AP and sections used to calculate amplitude and half-width.    
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Chapter 2 
Alfaxalone causes a reduction in inhibitory but not excitatory synaptic transmission 
or action potential firing in rat hypoglossal motor neurons in vitro 
Abstract 
We investigate the effects of alfaxalone on inhibitory glycinergic and excitatory 
glutamatergic synaptic transmission to rat hypoglossal motor neurons (HMNs). Whole-cell 
patch clamp recordings were made from neonatal (P7-14) rat HMNs within the hypoglossal 
nucleus in a 300µm thick transverse brainstem slice. Spontaneous and evoked excitatory 
post-synaptic currents (sEPSCs/eEPSCs), miniature glycinergic inhibitory post-synaptic 
currents (mIPSCs) were recorded at a holding potential of -60mV using CsCl-based 
internal solution. Action potential (AP) firing was recorded at a holding potential of -65mV 
using K+ methyl sulfate-based internal solution. A significant reduction in mIPSCs 
frequency (-39%) and amplitude (-54%) to HMNs were recorded indicating a reduction in 
inhibitory transmission to HMNs even in absence of action potential generation, possibly 
causing neuromotor excitation observed after alfaxalone administration in rats. 
Interestingly, this effect was also associated with a positive shift (+35%) in the baseline 
holding current (Iholding). Further, it was noted that alfaxalone, even at various 
concentrations (10nM-3µM), fails to alter either spontaneous or evoked (25µM only) EPSC 
frequency, amplitude, half-width, rise-time and Iholding. Similarly, repetitive AP firing by 
HMNs was not altered by alfaxalone. These results provide strong evidence for the 
hypothesis that neuromuscular excitation observed during alfaxalone anaesthesia in rats 
are most likely mediated by a selective decrease in inhibitory glycinergic synaptic inputs to 
brainstem motor neurons, without alteration in spontaneous or evoked excitatory synaptic 
transmission, and that HMNs are not excited sufficiently enough to bring about any 
changes in AP firing.  
 
Introduction  
Multiple reports suggest muscular rigidity and motor excitability after alfaxalone 
anaesthesia in several species like swine (Gonzalez et al., 2013), horses (Wakuno et al., 
2017), ponies (Deutsch et al., 2017a), cats (Deutsch et al., 2017b) and dogs (Maney, 
2017) which can be seen as limb paddling, psychomotor excitement, hyperaesthesia, 
minor to violent muscular twitching, stumbling, falling, etc. (Jones, 2012). This type of 
abnormal neuromotor response was also observed when a pilot study was conducted to 
evaluate effect of alfaxalone by various route of administrations and with common 
premedication agents in rats (Lau, 2013) and later in mice (Siriarchavatana et al., 2016). 
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Interestingly, Lau and colleagues report twitching behaviour in rats during induction as well 
as recovery periods of anaesthesia when administered by intraperitoneal (IP) route 
(20mg/kg) (Lau et al., 2013). This is a major drawback of alfaxalone anaesthesia in 
rodents as the twitching was reported to be severe in nature. The same study also 
suggests that even after use of several common premedications, complete blockage of 
twitching behaviour was not observed. Despite these shortcomings, when used at the 
correct dose, alfaxalone is considered a safe and reliable anaesthetic agent for dogs and 
cats; and has shown good sedative properties when used in combination with other agents 
in exotic species like wallabies, ferrets and rabbits (Jones, 2012). However, attempts to 
find a dose or suitable premedication for laboratory rodents have remained elusive.   
Anaesthetic agents in general, act either by potentiating inhibitory or by suppressing 
excitatory neurotransmission in more than one area of the brain. Traditionally, modulation 
of inhibitory neurotransmitter gamma (γ) aminobutyric acid type A (GABAA) receptor 
complex has been the major focus of studies involving alfaxalone, as it is believed to be 
the major site of action for producing anaesthesia and muscle relaxation (Albertson et al., 
1992). However, the severe twitching reported in rodents demands a closer investigation 
of alfaxalone effects on motor neurons.   
Interestingly, prior studies show that alfaxalone affects glycinergic currents in a 
dose-dependent manner. Glycine currents were inactive at low micromolar doses as 
shown in studies performed in cultured rat spinal neurones (Barker et al., 1987); rat 
cuneate nucleus slice preparation (Harrison & Simmonds, 1984); transfected HEK 293 
cells (Rick et al., 1998) and rat optic nerve preparation (Prince & Simmonds, 1992). 
However, at higher concentrations alfaxalone when tested on Xenopus laevis oocytes 
showed to enhance currents mediated by glycine receptors (Weir et al., 2004) via 
potentiating α-1 glycine receptor function (Mascia et al., 1996). A similar effect was 
reported when tested in HEK 293 cells transfected with α-1 glycine receptor (Ahrens et al., 
2008). Differences in these results point out the possible involvement of different glycine 
receptors subunits in the biological system. Although these studies did investigate the role 
of alfaxalone in modulating glycinergic transmission to some extent, none has investigated 
the direct effect on inhibitory and excitatory synaptic transmission to motor neurons. 
This led us to investigate the mechanism of possible modulation of synaptic 
neurotransmission to motor neurons by alfaxalone. Along with GABA, glycine is 
responsible for fast inhibitory neurotransmission in the central nervous system (CNS). Both 
neurotransmitters cause opening of chloride channels and inhibit the firing of neurons 
(Jentsch et al., 2002). Interestingly, glycine receptors are predominantly found in caudal 
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areas of the CNS, such as the brainstem and spinal cord, and are involved in the control of 
motor rhythm generation (Laube et al., 2002). A critical role of glycinergic 
neurotransmission in regulating muscle tone was also established when pharmacological 
blockage of glycine receptors by strychnine showed severe neuromotor symptoms, like 
cramps in skeletal muscles and increased sensitivity to external stimuli like sound 
(Callister & Graham, 2010; Yevenes & Zeilhofer, 2011). The involvement of glycinergic 
transmission in producing abnormal behavioural phenotypes is linked to mutations in the 
glycine receptor gene (Buckwalter et al., 1994; Mülhardt et al., 1994; Ryan et al., 1994). 
These mutations led to tremors, spasms and excessive startle responses in mutant mice, 
signs which are similar to those observed in dominant familial startle disease 
(hyperekplexia) in human subjects (Buckwalter et al., 1994; Koch et al., 1996). 
However, for rhythmic movements with precise control, the excitatory 
neurotransmitter, glutamate is also equally important in control of motor neuron excitability 
(Rekling et al., 2000). These excitatory inputs are responsible for repetitive firing in motor 
neurons that are in turn are responsible for tonic muscle contractions associated with 
postural control (Rekling et al., 2000). In light of this knowledge, it is very well possible that 
there is a alteration of either inhibitory and/or excitatory synaptic transmission to motor 
neurons, which could manifest as twitching in rats. Hence, to investigate the possible 
reason behind twitching behaviour in alfaxalone anaesthesia, the following study was 
undertaken to examine the modulation of inhibitory glycinergic and excitatory 
glutamatergic synaptic transmission by alfaxalone to brainstem motor neurons.   
 
Results 
Alfaxalone (25µM) reduces miniature glycinergic IPSC amplitude and frequency to 
rat hypoglossal motor neurons (HMNs) 
Earlier reports by Lau and colleagues (Lau, 2013) had suggested that alfaxalone 
reduces the inhibitory glycinergic synaptic transmission to rat HMNs. However, the study 
did not differentiate if this is an effect on action potential-independent spontaneous release 
of glycine or is mediated via action potential-dependent release of neurotransmitter 
glycine. Therefore, to test the effect of alfaxalone on inhibitory glycinergic synaptic 
transmission in the absence of spontaneous action potential generation, miniature IPSCs 
(mIPSCs) where recorded. The recording buffer in addition to NBQX (10µM), APV (50µM) 
and bicuculline (5µM) contained 1µM tetrodotoxin to block action potentials.  
Mean mIPSC amplitude was significantly reduced from -95.4 to -43.9pA (-54% 
change from control, p=0.0014, n=14, Fig 2.1E, Table 2.1). Similarly, there was also a 
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significant decrease in mIPSC frequency from 1.97 to 1.21Hz (-39% from control, 
p=0.0013, n=14, Fig 2.1C, Table 2.1). Figure 2.1F, G show the distribution of mIPSC 
amplitudes and inter-event intervals in control and alfaxalone conditions. The amplitude 
and inter-event interval distribution shows a significant shift toward low amplitude and high 
frequency events respectively (Kolmogorov-Smirnov test). Figures 2.1H, I show no change 
in mIPSC half-width and 10–90% rise time after alfaxalone application. It was interesting to 
note that baseline holding current (Iholding) showed a significant outward (positive) shift from 
-160.6 to -104.1pA (+35% from control, p=0.0039, n=14, Fig 2.1J, Table 2.1) in presence 
of alfaxalone which contradicts earlier report where a significant inward (negative) shift 
was noted when recording spontaneous IPSCs. This result shows that reduction of 
inhibitory glycinergic synaptic transmission is independent of action potential activity in 
HMNs. Similarly, a robust decrease in both frequency and amplitude of mIPSCs indicates 
a possible pre- and post-synaptic mechanism.   
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Figure 2.1 Alfaxalone (Alfa) reduces miniature inhibitory synaptic transmission to 
rat HMNs. 
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(A) A time line of the experimental protocol. After baseline control recording, slices were 
superfused with alfaxalone (25µM) dissolved in aCSF for 2-4min before recording the 
effect of alfaxalone on miniature inhibitory post-synaptic currents (mIPSCs). (B) 
Representative mIPSC frequency trace recorded under control and in presence of 25µM 
alfaxalone from HMNs voltage-clamped at -60mV. (C) Mean mIPSC frequency under 
control and alfaxalone conditions showing a significant decrease in frequency with 
alfaxalone. (D) Representative mIPSC amplitude showing a significant decrease after 
alfaxalone application. (E) Mean mIPSC amplitude significantly reduced after alfaxalone. 
Averaged cumulative frequency distribution of mIPSC amplitude (F) and inter-event 
interval (G). Kolmogorov-Smirnov test to amplitude and inter-event interval showed a 
significant difference between control and alfaxalone conditions. Mean mIPSC half-width 
(H) and rise time (I) remain unchanged after alfaxalone application. Baseline holding 
current (Iholding) (J), however showed a significant positive shift. All recordings were made 
with NBQX (10µM), APV (50µM), bicuculline (5µM) and 1µM tetrodotoxin (TTX) in the 
recording buffer. Data represented as mean ± S.D. for n=14 cells, each from a separate 
brain slice. Significance is shown as **p<0.01. A paired two-tailed t-test was used to 
determine whether the difference between data points under control and alfaxalone 
conditions was statistically significant. 
 
Table 2.1 Miniature IPSC parameters of HMNs upon application of alfaxalone to rat 
HMNs. 
Parameter Control 25µM Alfa Statistical 
Significance Mean ±SD n Mean ±SD n 
Amplitude (pA) -95.4 60.4 14 -43.9 21.7 14 ** p=0.0014 
Half-width (ms) 8.5 4.7 14 7.3 6.6 14 ns, p=0.39 
Rise time (ms) 2.4 1.8 14 3.2 2.9 14 ns, p=0.2 
Frequency (Hz) 1.97 0.8 14 1.21 0.7 14 ** p=0.0013 
Iholding (pA) -160.6 84.5 14 -104.1 50.4 14 ** p=0.0039 
 
Alfaxalone does not alter spontaneous excitatory synaptic transmission to rat 
hypoglossal motor neurons (HMNs) 
Our observation that mIPSC amplitude and frequency were reduced by alfaxalone 
raised the question of whether this effect was specific only to glycinergic 
neurotransmission or whether glutamatergic neurotransmission was also affected. To 
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investigate this, HMNs were voltage-clamped at a membrane potential of −60mV and were 
recorded in aCSF containing strychnine HCl (20µM) in order to block both glycine and 
GABAA receptor-mediated inhibitory synaptic currents in HMNs. During alfaxalone 
application period (5min for each concentration, 10nM to 3µM) there was no significant 
change in any of the shape parameters of sEPSCs like amplitude (Fig 2.2C), half-width 
(Fig 2.2D), rise time (Fig 2.2E), frequency (Fig 2.2F) and baseline holding current (Iholding) 
(Fig 2.2G, Table 2.2). This result shows that effect of alfaxalone is specific on inhibitory 
synaptic transmission and does not affect excitatory inputs to HMNs.     
 
Figure 2.2 Spontaneous excitatory post-synaptic currents (sEPSCs) to rat HMNs are 
unchanged after application of alfaxalone (Alfa). 
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(A) A time line of the experimental protocol. After baseline control recording, slices were 
superfused with various concentrations of alfaxalone (10nM-3µM) dissolved in aCSF for at 
least 5min before recording the effect of alfaxalone on sEPSCs (B) Representative sEPSC 
amplitude recorded under control and in presence of different concentrations of alfaxalone 
from HMNs voltage-clamped at -60mV. Mean sEPSC amplitude (C), half-width (D), rise 
time (E), frequency (F) and baseline holding current (Iholding) (G) remain unchanged after 
alfaxalone application. All recordings were made in the presence of 20µM strychnine HCl. 
Data represented as mean ± S.D. (n=16 for control, n=13 for 10nM to 300nM, n=15 for 
1µM and n=9 for 3µM). To check statistical significance, a linear regression was fitted to 
the mean and S.D. of different doses, to determine whether the slope was significantly 
different from zero. 
 
Table 2.2 Spontaneous EPSC parameters of rat HMNs upon application of 
alfaxalone. 
Parameter Control 10nM Alfa 30nM Alfa 
Mean ±SD n Mean ±SD n Mean ±SD n 
Amplitude (pA) -26.8 9.01 16 -24.1 6.64 13 -24.07 5.2 13 
Half-width (ms) 2.2 0.56 16 2.4 0.85 13 2.4 1.2 13 
Rise time (ms) 1.09 0.46 16 1.3 0.74 13 1.2 0.61 13 
Frequency (Hz) 2.33 1.24 16 3.029 1.29 13 2.5 1.06 13 
Iholding (pA) -127.3 101.5 16 -149.3 108 13 -155.1 113.5 13 
 
100nM Alfa 300nM Alfa 1µM Alfa 3µM Alfa 
Mean ±SD n Mean ±SD n Mean ±SD n Mean ±SD n 
-22.5 6.3 13 -25.2 8.1 13 -26.1 8.9 15 -28.4 11.7 9 
2.5 0.1 13 2.4 0.9 13 2.7 0.7 15 2.7 0.9 9 
1.2 0.6 13 1.2 0.6 13 1.4 0.6 15 1.3 0.5 9 
2.57 0.8 13 2.12 1.2 13 2.061 0.93 15 2.1 0.9 9 
-134.7 70.06 13 -161.5 140.7 13 -156.2 144.7 15 -188.4 140.5 9 
 
Evoked EPSC parameters and paired-pulse ratio (PPR) remain unchanged after 
alfaxalone application 
An earlier report (Lau, 2013) had suggested that alfaxalone, in addition to reducing 
spontaneous IPSCs, also reduced evoked IPSC amplitude in a dose dependent manner, 
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suggesting that there is a modulation of activity dependent inhibitory neurotransmitter 
release in the post-synaptic neuron. However, it remained unclear if activity dependent 
excitatory neurotransmitter release can also be modulated by alfaxalone application. To 
further investigate this, a pair of electrical stimuli in the reticular formation lateral to the 
hypoglossal nucleus were applied to evoke two excitatory currents separated by 150ms 
(Fig 2.3B). Fig 2.3C shows no change in the mean amplitude of the first evoked EPSC 
before and after application of alfaxalone (n=8, Table 2.3). Similarly, no change was 
observed in other shape parameters of evoked currents like half-width (Fig 2.3D) and rise 
time (Fig 3.3E) indicating that the post-synaptic excitatory neurotransmitter response is not 
altered by alfaxalone. The paired pulse ratio (PPR) of the the amplitude of the second to 
first eEPSCs was unchanged by alfaxalone (Fig 2.3G), providing further evidence that 
alfaxalone does not modulate action potential-dependent pre-synaptic release of 
glutamate. Similar to spontaneous recordings, the baseline holding current (Iholding) (Fig 
2.3F, Table 2.3) in evoked recordings remained unchanged. Our observations that 
alfaxalone alters only inhibitory synaptic transmission but fails to modulate spontaneous 
and activity-dependent excitatory currents emphasizes the fact that twitching seen during 
alfaxalone anaesthesia is solely because of its effect on inhibitory glycinergic synaptic 
transmission in the doses tested. 
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Figure 2.3 Evoked excitatory post-synaptic current (eEPSC) to rat hypoglossal 
motor neurons (HMNs) remain unchanged after application of alfaxalone (Alfa). 
A pair of stimulus currents of 0.5-1.1mA and 0.1ms duration was applied to evoke a pair of 
eEPSC. (A) Time line showing experimental protocol. After baseline control recording, 
slices were superfused with alfaxalone (25µM) dissolved in aCSF for 2-4min before 
recording the effect of alfaxalone on evoked excitatory post-synaptic currents (eEPSCs). 
(B) Examples of averaged eEPSCs traces in control or in presence of 25µM alfaxalone 
from HMN voltage-clamped at -60mV. Black triangles represent the time of stimulus 
current. (C) Mean eEPSC amplitude showed no change during alfaxalone treatment. 
Similarly, no significant change was observed in (D) half-width, (E) rise-time, (F) baseline 
holding current (Iholding) and (G) paired pulse ratio (EPSC2/EPSC1). 20µM strychnine HCl 
was present in the bath solution during all recordings. Data represented as mean ± S.D. 
for n=8 cells for all parameters. A paired two-tailed t-test was used to determine whether 
the difference between data points under control and alfaxalone conditions was statistically 
significant. 
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Table 2.3 Evoked EPSC parameters of rat HMNs upon application of alfaxalone. 
Parameter Control 25µM Alfa Statistical 
Significance Mean ±SD n Mean ±SD n 
Amplitude (pA) -231.9 99.8 8 -215.4 122.4 8 ns, p=0.43 
Half-width (ms) 10.1 5.4 8 8.5 7.1 8 ns, p=0.35 
Rise time (ms) 5.5 1.9 8 4.9 1.4 8 ns, p=0.098 
Iholding (pA) -47.3 61.6 8 -40.06 52.5 8 ns, p=0.38 
Paired Pulse Ratio 2.3 1.6 8 1.7 0.2 8 ns, p=0.31 
 
Action potential (AP) firing of HMNs remains unchanged after alfaxalone application                
Effect of alfaxalone on sIPSCs (Lau, 2013) and mIPSCs (present study) strongly suggest 
that it acts by reducing the pre-synaptic release of glycinergic neurotransmission. 
Furthermore, using evoked IPSC recordings, Lau and colleagues also suggest that there 
might be a post-synaptic modulation of glycine receptor activity by alfaxalone (Lau, 2013). 
Similarly, a negative and positive shift in baseline holding current during sIPSCs and 
mIPSCs respectively meant that there might be a modulation of post-synaptic HMN 
excitability after alfaxalone application. Endogenous steroids like corticosterone can 
reduce membrane excitability (Zakon, 1998) and this led us to investigate if alfaxalone, 
which shares structural similarity to the endogenous neurosteroid allopregnanolone, might 
also cause changes to membrane excitability and therefore to action potential firing. To 
make direct measurements of the effect of alfaxalone on post-synaptic HMN excitability, 
we evoked repetitive action potential (AP) firing from HMNs current clamped at −65mV, 
using a series of progressively increasing depolarizing current steps (Fig 2.4B). Frequency 
of repetitive AP firing remained unchanged from control to alfaxalone conditions (Fig 2.4C, 
H) (n=8, Table 2.4), nor did alfaxalone change the number of APs evoked by maximum 
current injected in individual cells (Fig 2.4E) (n=8, Table 2.4). Similarly, analysis of shape 
parameters of APs under control and alfaxalone conditions showed no significant change 
in AP amplitude (Fig 2.4D), half-width (Fig 2.4F) and rise slope (Fig 2.4G) (n=8, Table 2.4).  
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Figure 2.4 Repetitive action potential (AP) firing by HMNs is unchanged after 
alfaxalone (Alfa) application. 
(A) Time line showing experimental protocol. After baseline control recording, slices were 
superfused with alfaxalone (25µM) dissolved in aCSF for 2-4min before recording the 
effect of alfaxalone on repetitive action potential firing. (B) Depolarizing current steps 
caused steady-state membrane depolarization in the sub-threshold range (grey trace) and 
repetitive action potential firing in the supra-threshold range (black trace). (C,H) Alfaxalone 
(25µM) had no effect on the number of action potentials generated at the maximum 
amount of current injected neither the firing frequency was altered. (D) Quantification of 
mean AP amplitude showed no change after alfaxalone treatment. (E) Maximum number 
of APs generated at the highest injected current also remained unchanged. Other AP 
parameters like half-width (F) and max rise slope (G) were also unaffected by alfaxalone. 
Data represented as mean ± S.D. for n=8 cells, each from separate brain slice. A paired 
two-tailed t-test was used to determine whether the difference between data points under 
control and alfaxalone conditions was statistically significant. 
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Table 2.4 Repetitive action potential parameters of HMNs upon application of 
alfaxalone. 
Parameter Control 25µM Alfa Statistical 
Significance Mean ±SD n Mean ±SD n 
AP Amplitude (mV) 110.5 17.21 8 108.3 22.8 8 ns, p=0.68 
AP Half-width (ms) 1.463 0.165 8 1.491 0.2204 8 ns, p=0.59 
AP Max Rise slope (mV/ms) 98.5 12.08 8 97.51 26.15 8 ns, p=0.89 
Max AP count 27.13 6.792 8 25 4.84 8 ns, p=0.12 
 
Discussion  
Alfaxalone-induced neuromotor excitation in rats is seen as a major limitation, as 
spontaneous muscle contractions and muscle rigidity are unwanted side effects in any 
anaesthetic regime. These behavioural effects can also be compared to those observed in 
conditions like hyperekplexia, tetanus poisoning, and poisoing with seizure inducing 
compounds like strychnine. Abnormal suppression of glycine receptors or glycine release 
mechanisms are implicated in all the above mentioned conditions. In the case of 
alfaxalone, it is possible that a disruption of the inhibitory-excitatory balance to motor 
neurons is brought about by reduction of glycinergic transmission to motor neurons. The 
aim of our present study was to investigate if alfaxalone causes selective reduction of 
glycinergic inhibitory neurotransmission without altering excitatory glutamatergic 
neurotransmission. 
As a previous report showed a reduction in spontaneous IPSCs upon alfaxalone 
application in a dose dependent manner, we investigated if this holds true even after 
blockage of action potential generation. Hence, a study was designed where, in addition to 
a NBQX (10µM), APV (50µM) and bicuculline (5µM) cocktail, 1µM tetrodotoxin was also 
added to recording buffer to block action potentials. A high dose of alfaxalone (25µM) was 
selected for this study to observe full activation of all available receptor systems.  
As per traditional quantal analysis, a change in amplitude of miniature synaptic 
currents is taken as a change of post-synaptic receptor activity. Similarly, a change in the 
frequency is taken as a measure of pre-synaptic release probability (Redman, 1990; 
Stevens, 1993; Isaacson & Walmsley, 1995). As alfaxalone reduced mIPSC amplitude 
along with frequency, we conclude that alfaxalone causes both a decrease in post-
synaptic glycine responses and also a reduction in action-potential independent pre-
synaptic glycine release probability. Finally, as spontaneous currents include action 
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potential-independent miniature currents, and action potential dependent currents, we 
conclude that the decrease in sIPSC frequency (Lau, 2013) is due to a decrease in mIPSC 
frequency (present study).       
HMNs receive inhibitory (Lowe, 1978; Takagi et al., 2017) as well as excitatory 
(Koizumi et al., 2008; Revill et al., 2015) inputs from other regions in the brain. It was 
hence interesting to investigate whether the effect of alfaxalone is selective for glycinergic 
transmission, as in intact animals (as for the condition of anaesthesia) there is a possibility 
of feedback mechanism from other neurotransmitter systems. Hence, to investigate this, a 
dose response study was designed to check for any possible modulation of glutamatergic 
synaptic transmission to HMNs at increasing doses of alfaxalone (10nM to 3µM). No 
significant change was observed in any of the shape parameters recorded at all doses 
tested. This shows that there is a selective modulation of inhibitory glycinergic synaptic 
transmission to HMNs.  
However, it remained unclear if alfaxalone along with selective modulation of 
spontaneous glycinergic release also changes activity-dependent post-synaptic glutamate 
release machinery. Hence, in order to investigate this, evoked excitatory currents were 
recorded under control and alfaxalone conditions. However, no significant effect of 
alfaxalone on evoked EPSCs were observed, strongly suggesting that alfaxalone does not 
affect action potential-dependent post-synaptic glutamate release. 
Finally, we investigated the modulation of baseline holding current (Iholding) upon 
alfaxalone application. It was interesting to note that in the absence of tetrodotoxin 
(sIPSCs), a negative shift in holding current was observed which was not consistent with 
the one observed in presence of tetrodotoxin (mIPSCs), where a positive shift was 
observed which we believe, might be an effect of blockage of voltage gated sodium (Na+) 
channel current by TTX as they block the large transient currents during action potentials. 
Although the reasons behind this varying effect were not investigated further, it led to a 
new line of investigation, as a direct effect of changes in holding current could be a change 
in intrinsic excitability and therefore action potential firing rate of motor neurons. Hence, we 
tested if alfaxalone altered repetitive action potential (AP) firing by HMNs. Alfaxalone failed 
to alter repetitive firing in HMNs nor were there any changes in action potential shape 
parameters. These results indicate that alfaxalone does not affect motor neuron intrinsic 
excitability and the differences in the modulation of Iholding is perhaps due to activation of 
yet unidentified either cationic or anionic currents. Our study shows a decrease in action 
potential-independent release mechanism involved in the activity of alfaxalone, which do 
not involve modulation of voltage-gated sodium channels. In addition, no change in 
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spontaneous and evoked EPSC parameters was observed suggesting that alfaxalone 
does not directly modulate either pre-synaptic glutamate release or postsynaptic glutamate 
receptor activity.            
In conclusion, the synthetic neuroactive compound, alfaxalone, significantly reduces 
glycinergic inhibitory synaptic transmission to HMNs in brainstem slice preparation without 
affecting glutamatergic transmission. We also show that alfaxalone does not change 
intrinsic excitability of HMNs. This study expands our understanding regarding the 
modulation of synaptic transmission to motor neurons by alfaxalone, which can be a 
possible cause of excitatory responses observed in alfaxalone anaesthesia.  
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Chapter 3 
Capsaicin, a TRPV1 agonist, enhances excitatory synaptic transmission to rat 
hypoglossal motor neurons along with modulation of membrane holding current 
(Iholding)  
Abstract 
Our data from synaptic current recordings during alfaxalone application consistently 
showed a shift in Iholding, indicating an indirect modulatory effect. Steroids and steroid-like 
molecules can bring about modulation of several physiologically significant TRP channels. 
However, whether TRP channels are involved in the actions of alfaxalone that cause Iholding 
changes remains unknown. Hence, to further investigate this, the effects of capsaicin, a 
well-known TRPV1 agonist, on modulation of Iholding and synaptic transmission to HMNs 
were examined. Interestingly, we found that capsaicin at 1µM dose selectively increased 
only spontaneous excitatory post-synaptic current (sEPSC) frequency (+38%) without 
significantly affecting sEPSC amplitude. However, a higher concentration (10µM) caused a 
significant increase in both sEPSC frequency (+115%) as well as amplitude (+24%) 
recorded from neonatal rat HMNs. We further analysed miniature excitatory post-synaptic 
currents (mEPSCs), recorded in the presence of tetrodotoxin (TTX); capsaicin also 
increased mEPSC frequency, but mEPSC amplitude remained unchanged, indicating a 
pre-synaptic mechanism of action. Interestingly a negative shift in membrane current 
(Iholding) was elicited by capsaicin under all three recording conditions. The effect of 
capsaicin on sEPSC frequency remained unchanged in the presence of two different 
TRPV1 antagonists, capsazepine and SB366791, suggesting that capsaicin acts to 
increase EPSCs via a mechanism which does not require TRPV1 activation. Capsaicin, 
however, failed to alter evoked excitatory post-synaptic currents (eEPSCs) or the paired-
pulse ratio (PPR) of eEPSCs. Repetitive action potential (AP) firing in HMNs was also 
unaltered by capsaicin, indicating that capsaicin does not change HMN intrinsic 
excitability. Overall, these results show that capsaicin-like TRPV1 agonists can cause 
modulation of Iholding. However, in the present study; this effect is more likely due to an 
increase in glutamate release, rather than a direct effect of capsaicin on TRPV1 receptors, 
thereby indicating that alfaxalone induced changes in Iholding are mediated by mechanism 
that do not involve TRPV1.   
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Introduction  
A consistent observation upon alfaxalone application while recording synaptic 
currents in rat HMNs was a change in membrane holding current (Iholding), which we believe 
might drive the membrane potential to a more positive value, thereby contributing to motor 
neuron depolarization and thus may contribute to neuromotor excitation. In addition to this, 
there is also a possibility of generation and release of endogenous cannabinoids, as a rise 
in intracellular Ca2+ upon depolarization is one of the triggering mechanisms for 
endocannabinoid release. A shift in Iholding can be brought about by either Cl- efflux or 
cation influx. Although the source of this current remains unidentified, activation of the 
hyperpolarisation-activated cation (IH) current or modulation of several transient receptor 
potential (TRP) channels may be implicated as its source. Several neurotransmitters like 
5-HT (5-hydroxytryptamine), NE (norepinephrine) and glutamate can directly modulate the 
membrane current in motor neurons (Rekling et al., 2000). Similarly, IH current, which is 
reported in juvenile rat HMNs (Bayliss et al., 1994), is a rectifying cationic current that 
produces an increased inward membrane conductance during hyperpolarisation from 
resting membrane potential. However, another more interesting source of modulation of 
Iholding by steroids involve the activation of TRP channels, which constitute a large family of 
non-selective cation permeable channels and can bring about changes in intracellular 
calcium concentrations (Clapham et al., 2001; Moran et al., 2004; Desai & Clapham, 2005; 
Pedersen et al., 2005). Wagner and colleagues show that there is a direct and rapid 
activation of a specific TRP channel, TRPM3 by neuroactive steroid to cause the release 
of insulin from pancreatic cells (Wagner et al., 2008). This leads to the possibility that 
similar modulation of TRP channels by alfaxalone might be possible, considering the wide 
distribution of several families of TRP channels in the brain.  
We therefore hypothesis that the modulation of Iholding elicited by alfaxalone was due 
to TRP channel activation. Hence, we investigated the role of a well-known TRP vanilloid 
subtype-1 (TRPV1) agonist, capsaicin in modulating synaptic transmission to HMNs and 
particularly to check if Iholding is affected after its application. TRPV1 is a calcium permeable 
non-selective cation channel that is activated by the vanilloid capsaicin (Caterina et al., 
1997; Messeguer et al., 2006), acidic pH (<6) (Tominaga et al., 1998), heat (Caterina et 
al., 1997) or membrane depolarization (Voets et al., 2004). In the periphery, capsaicin 
stimulates TRPV1 channels in a subset of sensory afferent neurons, causing excitation 
and local release of inflammatory mediators (Caterina et al., 1997; Caterina et al., 2000). 
Activation of TRPV1 by capsaicin is known to initiate depolarization by the influx of sodium 
and calcium ions in peripheral sensory nerves, causing action potential generation and 
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propagation to the brainstem and spinal cord, ultimately giving rise to burning or itching 
sensations (Anand & Bley, 2011). 
The presence of TRPV1 on the central terminals of sensory afferents in the spinal 
cord and brainstem, as well as in several brain regions, including substantia nigra, locus 
coeruleus, hippocampus, nucleus tractus solitarius, periaqueductal grey and amygdala 
(Mezey et al., 2000; Roberts et al., 2004; Tóth et al., 2005; Sun et al., 2009; Aguiar et al., 
2015) is consistent with the results of electrophysiological studies demonstrating TRPV1-
mediated effects of capsaicin in these areas (Marinelli et al., 2002; Marinelli et al., 2003; 
Zschenderlein et al., 2011; Lu et al., 2017). These studies indicate that activation of 
TRPV1 by capsaicin can either modulate or directly release neurotransmitters in central 
neurons. 
However, whether TRP channels can modulate these excitatory inputs to HMNs 
remains a relatively unexplored question. In anesthetized rats, the administration of 
capsaicin directly into the right atrium to excite vagal pulmonary C fibres, has shown to 
lower hypoglossal nerve activity at low doses, while higher doses reduce phasic 
hypoglossal activity but increase tonic hypoglossal discharge (Lee et al., 2003), while 
capsaicin administration in the jugular vein suppresses HMN activity (Lee et al., 2007). 
Moreover, capsaicin has reported to rapidly increase inhibitory synaptic transmission to an 
adjacent brainstem structure, the dorsal motor nucleus of the vagus (DMVs) (Xu & Smith, 
2015) via a pre-synaptic mechanism. Similarly, capsaicin lowered respiratory motor output 
in medullary slice preparations in neonatal rats (MorgadoValle & Feldman, 2004). Most 
recently, Ren and collegues (Ren et al., 2017) showed that acting via TRPV1 receptors, 
capsaicin brings about an inhibition of the respiratory central pattern generator when 
tested in rhythmically active brainstem-spinal cord preparation. However, the direct effects 
of capsaicin on synaptic inputs to HMNs and changes associated with it are yet to be 
reported. 
 
Results 
Capsaicin (1µM) increases spontaneous excitatory post-synaptic current frequency 
to rat hypoglossal motor neurons (HMNs) 
Earlier capsaicin studies showed an increase in glutamatergic synaptic transmission in 
central neurons (Marinelli et al., 2002; Marinelli et al., 2003; Sikand & Premkumar, 2007). 
We therefore examined whether capsaicin altered spontaneous glutamatergic excitatory 
synaptic transmission (sEPSCs) to HMNs. During capsaicin application (8-14 min, 1µM), 
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there was a significant increase in sEPSC frequency without any change in amplitude (Fig 
3.1B-F). An increase in sEPSC frequency is shown by the representative traces in Fig 
3.1B. Fig 3.1C show mean sEPSC frequency increased from 2.5 to 3.5Hz (+38% from 
control, p=0.019, n=10). Mean sEPSC amplitude remained unchanged (Fig 3.1F). 
Distribution of sEPSC amplitude showed no shift to higher amplitude events in the 
presence of capsaicin (Fig 3.1D). However, the distribution of sEPSC inter-event intervals 
shows a significant shift towards smaller inter-event intervals representing a higher 
frequency (Fig 3.1E). Other sEPSC shape parameters, such as half-width (Fig 3.1G) and 
10-90% rise time (Fig 3.1H) remained unchanged after application of capsaicin. Baseline 
holding current (Iholding), however, showed a significant inward shift from -193.9 to -245.5pA 
(+27% from control, p=0.018, Fig 3.1I, Table 3.1). 
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Figure 3.1 1µM Capsaicin (Caps) increases glutamatergic excitatory post-synaptic 
current frequency to rat HMNs. 
(A) A time line of the experimental protocol. After baseline control recording, slices were 
superfused with capsaicin (1µM) dissolved in aCSF for 8-14min before recording the effect 
of capsaicin (Caps) on spontaneous excitatory post-synaptic currents (sEPSCs). (B) 
Representative sEPSCs recorded in the absence (control), and presence of 1µM capsaicin 
from a HMN voltage-clamped at -60mV. (C) Mean sEPSC frequency during control and 
capsaicin conditions showing a significant increase in sEPSC frequency with capsaicin. 
Averaged cumulative frequency distribution plots of sEPSC amplitude (D) and inter-event 
interval (E). Kolmogorov-Smirnov test of inter-event interval shows a significant difference 
between control and capsaicin conditions. Mean sEPSC amplitude (F) half-width (G) and 
rise time (H) remain unchanged after capsaicin application. Baseline holding current 
(Iholding) (I) did show a significant change in inward direction after capsaicin. All recordings 
were made in the presence of 20µM strychnine HCl. Data represented as mean ± S.D. for 
n=10 cells, each from a separate brain slice. Significance is shown as *p<0.05. A paired 
two-tailed t-test was used to determine whether the difference between data points under 
control and capsaicin conditions was statistically significant. 
 
Table 3.1 Spontaneous EPSC parameters of neonatal rat HMNs upon application of 
1µM capsaicin. 
Parameter Control 1µM Caps Statistical 
Significance Mean ±SD n Mean ±SD n 
Amplitude (pA) -26.4 4.7 10 -33.5 12.8 10 ns, p=0.08 
Half-width (ms) 2.5 1.3 10 2.7 1.2 10 ns, p=0.34 
Rise time (ms) 1.15 0.64 10 1.2 0.7 10 ns, p=0.56 
Frequency (Hz) 2.58 1.09 10 3.57 1.26 10 *p=0.019 
Iholding (pA) -193.9 139.6 10 -245.5 129.4 10 *p=0.018 
 
Capsaicin (10µM) increases spontaneous excitatory post-synaptic current frequency 
and amplitude to rat hypoglossal motor neurons (HMNs) 
An increase in sEPSC frequency upon application of 1µM capsaicin was also 
associated with an increase in amplitude of currents. This effect, although not significant, 
showed a strong trend towards an increase in amplitude of currents (+27% from control). 
This result may mean that there was an insufficient activation of all available receptors in 
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the brainstem slice preparation. Earlier studies used capsaicin in a safe and reliable 
manner even at much higher concentration during patch-clamp recordings (Morgado-Valle 
& Feldman, 2004; Gavva et al., 2005; Benninger et al., 2008). Hence, in order to 
maximally activate all available receptors and to obtain a robust effect after application, a 
higher concentration of capsaicin was selected (10µM). sEPSCs were again recorded, this 
time with a bath application of 10µM capsaicin. 
During capsaicin application (9-11min, 10µM), there was a significant increase in 
both sEPSC frequency and amplitude (Fig 3.2B-G). Increased sEPSC frequency is 
illustrated by the representative traces in Fig 3.2B. Mean sEPSC frequency was also 
increased from 1.34 to 2.89Hz (+115% from control, p=0.013; Fig 3.2C). A washout of 
15min partially restored sEPSC amplitude and frequency towards control values. Fig 3.2D 
represents averaged spontaneous EPSCs from the three time periods shown, illustrating 
increased sEPSC amplitude with capsaicin and a partial washout of this effect. Mean 
sEPSC amplitude increased from -20.3 to -25.3pA (+24% from control, p=0.018, n=7; Fig 
3.2E). The distribution of sEPSC amplitude showed a shift to higher amplitude events in 
the presence of capsaicin (Fig 3.2F). Similarly, the distribution of sEPSC inter-event 
intervals shows a significant shift towards smaller inter-event intervals (equating to higher 
frequency), which returned toward control values upon washout (Fig 3.2G). Other sEPSC 
shape parameters, such as half-width (Fig 3.2H) and 10-90% rise time (Fig 3.2I) remained 
unchanged during capsaicin application. Baseline holding current (Iholding), however, did 
show a significant inward shift from -95.75 to -116.6pA (+21% from control, p=0.0003, Fig 
3.2J), and this effect also partially recovered after washout.     
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Figure 3.2 10µM Capsaicin (Caps) increases glutamatergic excitatory post-synaptic 
current frequency and amplitude to rat HMNs. 
(A) A time line of the experimental protocol. After baseline control recording, slices were 
superfused with capsaicin (10µM) dissolved in aCSF for 9-11min before recording the 
effect of capsaicin (Caps) on spontaneous excitatory post-synaptic currents (sEPSCs). 
Followed by a 15min wash with aCSF devoid of Caps. (B) Representative sEPSCs 
recorded in the absence (control), and presence of 10µM capsaicin, and after 15min wash 
from a HMN voltage-clamped at -60 mV. (C) Mean sEPSC frequency during control, 
capsaicin and wash conditions, showing a significant increase in sEPSC frequency with 
capsaicin. (D) Representative averaged amplitude traces of sEPSCs before (control), 
during capsaicin and after wash. (E) Mean sEPSC amplitude during control, capsaicin and 
wash conditions, showing a significant increase in sEPSC amplitude with capsaicin. 
Averaged, cumulative frequency distribution plots of sEPSC amplitude (F) and inter-event 
interval (G) for HMNs in C and E. Kolmogorov-Smirnov test of inter-event interval shows a 
significant difference between control and capsaicin conditions. Mean sEPSC half-width 
(H) and rise time (I) remain unchanged after capsaicin application. (J) baseline holding 
current (Iholding) was significantly altered in inward direction by capsaicin. All recordings 
were made in the presence of 20µM strychnine HCl. Data represented as mean ± S.D. for 
n=7 cells, each from a separate brain slice. Significance is shown as *p<0.05, ***p<0.001. 
A paired two-tailed t-test was used to determine whether the difference between data 
points under control, capsaicin and wash conditions was statistically significant. 
 
Table 3.2 Spontaneous EPSC parameters of neonatal rat HMNs upon application of 
10µM capsaicin. 
Parameter Control 10µM Caps 15 min Wash 
Mean ±SD n Mean ±SD n Mean ±SD n 
Amplitude (pA) -20.3 4.6 7 -25.3 6.1 7 -22.5 7.1 7 
Half-width (ms) 2.8 1.0 7 3.1 1.5 7 3.6 1.0 7 
Rise time (ms) 1.6 0.8 7 1.4 0.9 7 1.8 0.5 7 
Frequency (Hz) 1.34 0.5 7 2.89 1.3 7 1.90 0.6 7 
Iholding (pA) -95.75 47.1 7 -116.6 51.1 7 -102.6 39.2 7 
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Parameter Statistical Significance 
Control vs 10µM Caps 
Statistical Significance 
Control vs 15 min Wash 
Amplitude (pA) * p=0.018 ns, p=0.24 
Half-width (ms) ns, p=0.42 ns, p=0.12 
Rise time (ms) ns, p=0.54 ns, p=0.48 
Frequency (Hz) * p=0.013 ns, p=0.11 
Iholding (pA) *** p=0.0003 ns, p=0.47 
 
Effect of capsaicin (10µM) on frequency of excitatory post-synaptic currents is 
mediated via a TTX-insensitive mechanism 
Capsaicin-induced changes in sEPSCs can either be an effect on action potential-
independent spontaneous release of glutamate, or may, in part, be mediated via action 
potential-mediated release of neurotransmitters. Hence, to further test the effect of 
capsaicin on excitatory synaptic transmission in the absence of spontaneous action 
potential generation, we analysed miniature EPSCs (mEPSCs) where, in addition to 
strychnine, 1µM tetrodotoxin (TTX) was added to completely block action potentials. Mean 
mEPSC frequency was still significantly increased by capsaicin, from 2.65 to 7.5Hz 
(+183% from control, p=0.0026, n=10, Fig 3.3C). However, there was no change in 
mEPSC amplitude after capsaicin application (Fig 3.3F). Fig 3.3D and E show the 
distribution of mEPSC amplitudes and inter-event intervals in control and capsaicin 
conditions. The amplitude distribution shows no significant change (Fig 3.3D), however, 
inter-event interval distribution shows a significant shift towards higher frequency (Fig 
3.3E, Kolmogorov-Smirnov test). Similar to sEPSCs, there were no significant changes in 
mEPSC half-width (3.3G) and 10-90% rise time (Fig 3.3H). Baseline holding current 
(Iholding) again showed a significant inward shift from -55.99 to -81.72 pA (+45% from 
control, p=0.014, n=10, Fig 3.3I). Together, these effects of capsaicin on sEPSCs and 
mEPSCs show that capsaicin acts by increasing the release probability of pre-synaptic 
terminals or by modulating the excitability of pre-synaptic neurons making excitatory inputs 
to HMNs. 
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Figure 3.3 10µM Capsaicin (Caps) induced increase in sEPSC frequency but not 
amplitude is mediated via non-TTX sensitive mechanism.    
(A) A time line of the experimental protocol. After baseline control recording, slices were 
superfused with capsaicin (10µM) dissolved in aCSF for 9-11min before recording the 
effect of capsaicin (Caps) on spontaneous excitatory post-synaptic currents (sEPSCs). All 
recordings were made in the presence of 1µM tetrodotoxin (TTX) and 20µM strychnine 
HCl. (B) Representative mEPSCs recorded in the absence (control) and presence of 10µM 
capsaicin from a HMN voltage-clamped at -60mV. (C) Mean mEPSC frequency shows a 
significant increase during capsaicin application. Averaged cumulative frequency 
distribution plots of mEPSCs amplitude (D) and inter-event interval (E). Kolmogorov-
Smirnov test applied to inter-event interval shows a significant difference between control 
and capsaicin. (F-H) shows amplitude, half-width and rise-time of mEPSCs which were 
unchanged during capsaicin application. (I) baseline holding current (Iholding) showed an 
inward shift with capsaicin. Data represented as mean ± S.D. for n=10 cells, each from a 
separate brain slice. Significance is shown as *p<0.05, **p<0.01. A paired two-tailed t-test 
was used to determine whether the difference between data points under control and 
capsaicin conditions was statistically significant. 
 
Table 3.3 Miniature EPSC parameters of neonatal rat HMNs upon application of 
10µM capsaicin. 
Parameter Control 10µM Caps Statistical 
Significance Mean ±SD n Mean ±SD n 
Amplitude (pA) -17.6 4.9 10 -17.8 7.7 10 ns, p=0.94 
Half-width (ms) 2.0 0.4 10 2.0 0.3 10 ns, p=0.89 
Rise time (ms) 1.4 1.0 10 0.7 0.2 10 ns, p=0.07 
Frequency (Hz) 2.65 1.4 10 7.50 3.6 10 ** p=0.0026 
Iholding (pA) -55.99 60.1 10 -81.72 71.0 10 * p=0.014 
 
TRPV1 antagonists do not block the effect of capsaicin on sEPSC frequency 
Next, we investigated if the actions of capsaicin are mediated via TRPV1 activation, 
by testing whether pre-application of the TRPV1 antagonist capsazepine (Urban & Dray, 
1991) could block the effect of capsaicin on glutamatergic excitatory transmission to rat 
HMNs. Earlier reports show that application of capsaicin in brain slice preparations 
(Marinelli et al., 2002) and cultured neurons (Sikand & Premkumar, 2007) increased 
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excitatory transmission through activation of TRPV1 receptors and that this effect was 
abolished by capsazepine.  
Application of capsaicin in the presence of capsazepine still increased sEPSC 
frequency (+123% from control, p=0.0038, n=9; Fig 3.4C) and Iholding (+25% from control, 
p=0.0047, n=9; Fig 3.4J), but had no effect on amplitude (Fig 3.4H). Fig 3.4B represents 
the increase in frequency after addition of capsaicin in presence of capsazepine. Fig 3.4D 
shows averaged amplitude under 3 different conditions (control, capsazepine and 
capsazepine + capsaicin) respectively. It was interesting to note that capsaicin in presence 
of capsazepine increases the half-width of spontaneous currents (+30% from control, 
p=0.032, n=9; Fig 3.4E). The amplitude distribution of sEPSC showed a significant shift 
towards lower amplitude upon capsazepine application, but showed no further change 
after capsaicin application (Fig 3.4F). Also, the distribution of inter-event intervals showed 
no change between control and capsazepine, but showed a significant shift towards 
shorter inter-event intervals upon addition of capsaicin (Fig 3.4G). Capsazepine alone did 
not cause any significant effect on sEPSC frequency (Fig 3.4C), half-width (3.4E), rise time 
(3.4I) and Iholding (3.4J); however, there was a significant decrease in sEPSC amplitude (-
19% from control, p=0.028, n=9, Fig 3.4H), indicating a partial tonic effect of TRPV1 on 
sEPSC amplitude.  
We therefore used a structurally different, selective, and potent TRPV1 antagonist, 
SB366791 (Gunthorpe et al., 2004; Varga et al., 2005), in order to further test the 
involvement of TRPV1 receptors in the actions of capsaicin. Earlier reports have shown 
that SB366791 antagonized capsaicin-induced changes in brain slice preparations 
(Gunthorpe et al., 2004; Varga et al., 2005). As for capsazepine, SB366791 did not alter 
the effect of capsaicin on sEPSC frequency (+94% from control, n=6, p=0.063; Fig 3.5C), 
but did block the effect of capsaicin on sEPSC amplitude (Fig 3.5B) and Iholding (Fig 3.5H). 
The averaged sEPSC amplitude distribution showed no significant change between either 
control-SB366791 or control-capsaicin conditions (Fig 3.5D). Similarly, the averaged inter-
event intervals distribution showed no change with SB366791, but showed a significant 
shift in events towards higher frequency when capsaicin was added (Fig 3.5E). No 
significant changes were observed in sEPSC half-width (Fig 3.5F) and 10-90% rise time 
(Fig 3.5G) under all conditions tested. By contrast to capsazepine, which decreased 
sEPSC amplitude, SB366791 by itself had no effect on sEPSC amplitude, indicating 
absence of any tonic SB366791-sensitive activity.     
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Figure 3.4 Pre-application of the TRPV1 antagonist, capsazepine (Capz), blocked the 
effect of capsaicin (Caps) on sEPSC amplitude but not on frequency. 
(A) Experimental protocol timing. After recording baseline control activity, slices were 
superfused with capsazepine (Capz, 10µM) in aCSF for 5min before recording 
capsazepine-induced changes in sEPSCs. Finally, capsaicin (10µM) in aCSF was added 
for 9-11min after which capsaicin induced sEPSC responses were recorded. 
Representative traces for sEPSC frequency (B) under control, capsazepine and 
capsazepine + capsaicin conditions. (C) Averaged frequency plot showing significant 
increase after capsaicin application even in presence of capsazepine. (D) Representative 
amplitude for sEPSC frequency under all 3 conditions. (E) Mean half-width plot showing 
significant increase after capsaicin. Averaged cumulative frequency distribution plots of 
sEPSC amplitude (F) and inter-event interval (G). Kolmogorov-Smirnov test shows 
significant difference between control vs capsazepine condition in amplitude plot and a 
significant difference between control and capsaicin condition in inter-event interval plot. 
(H) Mean sEPSC amplitude plot shows a significant decrease in amplitude after 
capsazepine alone, but no change after capsaicin application. (I) Mean sEPSC rise time 
was not altered after capsazepine or capsaicin application. (J) Mean baseline holding 
current (Iholding) was significantly altered after capsaicin, but not after capsazepine 
application alone. All recordings were made in the presence of 20µM strychnine HCl. Data 
represented as mean ± S.D. for n=9 cells, each from a separate brain slice. Significance is 
shown as *p<0.05, **p<0.01. A paired two-tailed t-test was used to determine whether the 
difference between data points under control, capsazepine and capsaicin + capsazepine 
conditions was statistically significant. 
 
Table 3.4 Spontaneous EPSC parameters of neonatal rat HMNs upon application of 
10µM capsaicin in presence of 10µM capsazepine. 
Parameter Control 10µM Capz 10µM Caps 
Mean ±SD n Mean ±SD n Mean ±SD n 
Amplitude (pA) -23.3 7.4 9 -18.8 4.3 9 -27.9 9.9 9 
Half-width (ms) 2.8 0.9 9 2.4 0.8 9 3.6 1.0 9 
Rise time (ms) 1.5 0.5 9 1.4 0.6 9 1.6 0.2 9 
Frequency (Hz) 1.40 0.7 9 1.24 0.8 9 3.14 1.1 9 
Iholding (pA) -80.26 92.5 9 -85.4 92.6 9 -100.7 78.9 9 
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Parameter Statistical Significance 
Control vs 10µM Capz 
Statistical Significance 
Control vs 10µM Caps 
Amplitude (pA) * p=0.029 ns, p=0.17 
Half-width (ms) ns, p=0.18 * p=0.033 
Rise time (ms) ns, p=0.53 ns, p=0.75 
Frequency (Hz) ns, p=0.31 ** p=0.0038 
Iholding (pA) ns, p=0.32 ** p=0.0047 
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Figure 3.5 Pre-application of the TRPV1 antagonist, SB366791, blocked the effect of 
capsaicin (Caps) on sEPSC amplitude but not on frequency. 
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(A) Experimental protocol timing. After recording baseline control activity, slices were 
superfused with SB366791 (20µM) prepared in aCSF for 5min before recording SB366791 
induced sEPSC responses. Finally, capsaicin (10µM) prepared in aCSF was added for 9-
11min, and then capsaicin induced sEPSC activity was recorded. (B) Mean amplitude 
scatter plot shows no difference between control, SB366791 or capsaicin conditions. (C) 
Mean frequency scatter plot shows a significant change after capsaicin, but no change 
with SB366791 application alone. Averaged cumulative frequency distribution plots of 
sEPSC amplitude (D) and inter-event interval (E). Kolmogorov-Smirnov test of inter-event 
intervals shows a significant difference between control vs SB366791 and control vs 
capsaicin conditions. sEPSC half-width (F), rise time (G) and baseline holding current 
(Iholding) (H) remained unchanged under SB366791 or capsaicin conditions. All recordings 
were made in the presence of 20µM strychnine HCl. Data represented as mean ± S.D. for 
n=6 cells, each from separate brain slice. Significance is shown as **p<0.01. A paired two-
tailed t-test was used to determine whether the difference between data points under 
control, SB366791 and capsaicin + SB366791 conditions was statistically significant. 
 
Table 3.5 Spontaneous EPSC parameters of neonatal rat HMNs upon application of 
10µM capsaicin in presence of 20µM SB366791. 
Parameter Control 20µM SB366791 10µM Caps 
Mean ±SD n Mean ±SD n Mean ±SD n 
Amplitude (pA) -23.1 4.1 6 -21.8 2.6 6 -21 6.2 6 
Half-width (ms) 1.9 0.7 6 2.0 0.6 6 2.3 1.2 6 
Rise time (ms) 1.0 0.6 6 1.1 0.2 6 1.2 0.4 6 
Frequency (Hz) 2.55 0.8 6 1.98 0.7 6 4.96 1.5 6 
Iholding (pA) -58.89 65.6 6 -58.96 56.4 6 -78.54 62.0 6 
 
Parameter Statistical Significance 
Control vs 20µM SB366791 
Statistical Significance 
Control vs 10µM Capsaicin 
Amplitude (pA) ns, p=0.18 ns, p=0.49 
Half-width (ms) ns, p=0.53 ns, p=0.44 
Rise time (ms) ns, p=0.55 ns, p=0.55 
Frequency (Hz) ns, p=0.063 ** p=0.0016 
Iholding (pA) ns, p=0.99 ns, p=0.34 
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Capsaicin (10µM) does not alter evoked EPSC parameters or paired-pulse ratio 
(PPR) 
As capsaicin increased both sEPSC and mEPSC frequency, capsaicin may act via 
a pre-synaptic mechanism that is not mediated via classic TRPV1 activation. To further 
differentiate between modulation of activity-dependent and -independent transmitter 
release, we analysed the effects of capsaicin on evoked excitatory post-synaptic currents 
(eEPSCs). Two stimuli in the reticular formation lateral to the hypoglossal motor nucleus 
evoked a pair of short-latency multi-synapse excitatory currents (average first eEPSC 
amplitude=237.9 ± 68.8pA, n=11) separated by 150ms. As shown in Fig 3.6, the first 
eEPSC before and after application of capsaicin showed no change in amplitude (Fig 
3.6C), rise time (Fig 3.6D) and half-width (Fig 3.6E), suggesting that activity-dependent 
release is not altered by capsaicin. This interpretation was strengthened by a lack of effect 
of capsaicin on the PPR of the first and second eEPSCs (Fig 3.6G). As for our 
observations of sEPSCs and mEPSCs, there was a negative shift in Iholding while recording 
eEPSCs, but we found no associated change in HMN input resistance (Fig 3.6H).   
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Figure 3.6 Evoked excitatory post-synaptic current (eEPSC) to rat hypoglossal 
motor neurons (HMNs) were unchanged after application of capsaicin. 
(A) Experimental protocol timing. A pair of stimulus currents of 0.5-1.1mA and 0.1ms 
duration was applied to evoke a pair of eEPSC. After recording baseline control 
responses, slices were superfused with capsaicin (10µM) in aCSF for 9-11min before 
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recording the capsaicin induced eEPSC responses. (B) Examples of averaged eEPSCs 
traces in control or in presence of 10µM capsaicin from HMN voltage-clamped at -60mV. 
Black triangles represent the time of stimulus current. (C) eEPSC amplitude showed no 
change during capsaicin treatment. Similarly, no significant change is observed in (D) rise-
time, (E) half-width, (G) paired pulse ratio (EPSC2/EPSC1) and (H) input resistance. 
However, there was a significant shift in the baseline holding current (F). 20µM strychnine 
HCl was present during recordings. Data represented as mean ± S.D. for n=8 cells for 
input resistance and n=11 cells for all other parameters. Significance is shown as 
**p<0.01. A paired two-tailed t-test was used to determine whether the difference between 
data points under control and capsaicin conditions was statistically significant. 
 
Table 3.6 Evoked EPSC parameters of neonatal rat HMNs upon application of 10µM 
capsaicin. 
Parameter Control 10µM Caps Statistical 
Significance Mean ±SD n Mean ±SD n 
Amplitude (pA) -237.9 68.8 11 -213.9 68.3 11 ns, p=0.25 
Half-width (ms) 9.9 6.5 11 8.3 3.8 11 ns, p=0.42 
Rise time (ms) 6.7 2.6 11 7.4 4.0 11 ns, p=0.61 
Paired Pulse Ratio 1.46 0.1 11 1.576 0.2 11 ns, p=0.17 
Iholding (pA) -56.63 76.9 11 -103 103.4 11 ** p=0.0033 
Input Resistance (MΩ) 124.7 47.9 08 130.9 55.0 08 ns, p=0.13 
 
Capsaicin (10µM) does not affect repetitive action potential (AP) firing of HMNs 
The effects of capsaicin on sEPSCs and mEPSCs strongly suggests it acts by 
increasing the release probability of pre-synaptic neuron terminals, with little post-synaptic 
effect on HMN excitability, although capsaicin consistently evoked an inward current in all 
conditions tested. To directly measure the effect of capsaicin on post-synaptic HMN 
excitability, we evoked repetitive action potential (AP) firing from HMNs current clamped at 
-65mV, using a series of progressively increasing depolarizing current steps (Fig 3.7B). 
Capsaicin did not change AP firing frequency in HMNs (n=9, Fig 3.7C and D), nor did 
capsaicin change the number of APs evoked by maximum current injected in individual 
cells (Fig 3.7F). Analysis of shape parameters of APs under control and capsaicin 
conditions showed no significant change in AP amplitude (Fig 3.7E), rise slope (Fig 3.7G), 
half-width (Fig 3.7H) and after-hyperpolarisation amplitude (Fig 3.7I). Capsaicin also had 
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no effect on the minimum amount of current required to generate the first AP under both 
conditions tested (Fig 3.7K). However, it was interesting to note that under the recording 
conditions used for APs (holding potential, -65mV and potassium methyl sulfate-based 
internal solution), there was no significant shift in Iholding (Fig 3.7J). 
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Figure 3.7 Repetitive action potential (AP) firing by HMNs is unchanged after 
capsaicin application. 
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(A) Experimental protocol timing. After baseline control recording, slices were superfused 
with capsaicin (10µM) dissolved in aCSF for 9-11min before recording the effect of 
capsaicin (Caps) on repetitive action potential firing. (B) Depolarizing current steps caused 
steady-state membrane depolarization in the sub-threshold range (grey trace) and 
repetitive action potential firing in the supra-threshold range (black trace). (C) Capsaicin 
(10µM) had no effect on the number of action potentials generated at the maximum 
amount of current injected. (D) Quantification of mean firing rate at the maximum current 
injected showed no change during capsaicin. All other action potential parameters, 
including amplitude (E), max AP count (F), rise slope (G), half-width (H), after-
hyperpolarization amplitude (I) remained unchanged. Baseline holding current (Iholding) (J) 
and minimum current required to generate first AP (K) also remained unchanged during 
capsaicin. Data represented as mean ± S.D. for n=9 cells, each from separate brain slice. 
A paired two-tailed t-test was used to determine whether the difference between data 
points under control and capsaicin conditions was statistically significant. 
 
Table 3.7 Repetitive action potential (AP) firing parameters of neonatal rat HMNs 
upon application of 10µM capsaicin. 
Parameter Control 10µM Caps Statistical 
Significance Mean ±SD n Mean ±SD n 
AP Amplitude (mV) 115.8 16.8 9 105.3 23.0 9 ns, p= 0.088 
AP Half-width (ms) 1.4 0.4 9 1.5 0.3 9 ns, p= 0.27 
AP Max Rise slope 
(ms) 
102.0 30.5 9 90.2 23.3 9 ns, p= 0.11 
After Hypolarization 
Amplitude (mV) 
-11.01 3.7 9 -11.27 4.3 
 
9 ns, p= 0.68 
Iholding (pA) -41.25 11.6 9 -36.08 17.7 9 ns, p= 0.19 
Max AP count 8.963 3.8 9 9.185 4.1 9 ns, p= 0.59 
Min. Current required 
to generate 1st AP 
29.33 20.48 9 27.22 19.22 9 ns, p= 0.32 
 
Discussion 
Our present study shows that capsaicin, a TRPV1 receptor agonist, increases 
glutamatergic synaptic transmission to rat HMNs at two different concentrations (1 and 
10µM). This effect was associated with a negative shift in the baseline holding current 
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(Iholding). When tested in presence of TTX, an increase in frequency of excitatory currents 
remained unchanged, as did a change in Iholding. Evoked excitatory synaptic currents 
showed no change in the presence of capsaicin, consistent with pre-synaptic 
enhancement of action potential-independent release probability. Further testing of the 
effect of capsaicin on excitatory synaptic current frequency in presence of two TRPV1 
antagonists showed no blockage of effects on sEPSC frequency, suggesting that this 
effect is via a mechanism that does not require TRPV1 receptor activation. We also show 
that capsaicin application did not change repetitive AP firing in HMNs.  
However, it was interesting to note that capsaicin consistently caused a shift in 
membrane current during mEPSC, sEPSC and evoked EPSC recordings. The most 
conservative mechanism for this inward current is an increase in tonic activation of 
glutamate receptors, presumably secondary to increased mEPSC frequency. This raises 
the question of where this input comes from. HMNs receive strong glutamatergic inputs 
from several regions, including respiratory central drive from Dbx1 positive interneurons in 
the reticular formation (Koizumi et al., 2008; Revill et al., 2015). It is likely that these last 
order premotor interneurons also integrate inputs from vagal afferent-driven NTS neurons 
(Bailey et al., 2002; Bailey & Fregosi, 2006; Beaumont et al., 2017), as well as TRPV1 
positive trigeminal somatosensory neurons (Cavanaugh et al., 2011), as in vivo studies 
show that respiratory rhythm drives and modulates both whisking and sniffing behaviours 
(Moore et al., 2013; Moore et al., 2014). Recently, capsaicin, acting via TRPV1 receptors, 
has shown to cause potent inhibition of the respiratory central pattern generator in the 
rhythmically active brainstem-spinal cord in vitro preparation and in plethysmographic in 
vivo recordings, but had no effect in a rhythmically active brainstem slice (Ren et al., 
2017).  Interestingly, respiratory apnoea was often accompanied by increased tonic motor 
activity (Ren et al., 2017), which is consistent with our interpretation, and with a study by 
Lee and colleagues, where increased tonic hypoglossal discharge was reported (Lee et 
al., 2003) at higher concentrations of capsaicin in anaesthetised rats.  
However, other structures may provide capsaicin-sensitive afferent inputs to HMNs.  
TRPV1-positive vagal nerve afferents arborize extensively in structures adjacent to the 
hypoglossal motor nucleus, including the dorsal motor nucleus of the vagus, and the 
nucleus of the solitary tract (Kalia & Sullivan, 1982; Hermes et al., 2016). Synaptic 
transmission to neurons in these structures is modulated by capsaicin, increasing 
excitatory spontaneous release (Shoudai et al., 2010)  and reducing miniature inhibitory 
post-synaptic currents (Xu & Smith, 2015). It is possible that these modulated vagal 
afferents may contribute to the enhancement of glutamatergic transmission by capsaicin in  
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HMNs. As capsaicin took around 9-11mins to produce effects in our study, it is also 
possible that the effect seen in HMNs may be mediated by spread of a secondary 
messenger, such as endocannabinoids or endovanilloids.  
The vanilloid capsaicin is one of the five major capsaicinoids present in chili 
peppers (Barbero et al., 2014). The effects of capsaicin are usually attributed to activation 
of TRPV1 channels (Caterina et al., 1997; Messeguer et al., 2006), and are blocked by 
specific antagonists of TRPV1. In our study, we used capsazepine, an antagonist of 
TRPV1 channels (Marinelli et al., 2002; Marinelli et al., 2003), to see if its pre-application 
can block the effect of capsaicin on sEPSCs.  Although capsazepine is a competitive 
antagonist of TRPV1 receptors (Docherty et al., 1997), capsazepine can act on several 
other ion channels and receptors, including voltage-activated calcium channels (Docherty 
et al., 1997), nicotinic acetylcholine receptors (Liu & Simon, 1997), and hyperpolarisation-
activated cyclic nucleotide-gated channels (Gunthorpe et al., 2004). Capsazepine also 
shows species-related variable effects on calcium influx (Savidge et al., 2002) and hence 
may be a less potent TRPV1 antagonist in mouse and rat (Correll et al., 2004). Although 
capsazepine did block the effect of capsaicin on sEPSC amplitude, it did not block the 
effects on sEPSC frequency and Iholding. These results suggest capsaicin increases action 
potential-independent glutamatergic transmission by a mechanism other than TRPV1 
activation. Our interpretation is further supported by reports that capsaicin elicited 
increases in sEPSC frequency in both wild type and TRPV1 knock-out mice (Benninger et 
al., 2008), indicating that modulation of excitatory synaptic transmission by capsaicin is not 
always mediated by TRPV1 channels. 
Although capsaicin is a highly potent agonist for the TRPV1 receptor, some of the 
actions of capsaicin may not be mediated by TRPV1 receptors. Capsaicin is reported to 
directly inhibit voltage-gated sodium (Balla et al., 2001; Liu et al., 2001; Lundbaek et al., 
2005; Cao et al., 2007; Wang et al., 2007) as well as calcium (Köfalvi et al., 2006) 
channels. As we saw pre-synaptic effects of capsaicin in the presence of TTX, we can rule 
out direct modulation of voltage-gated sodium channels, while the absence of any change 
in evoked EPSC amplitude or paired-pulse ratio strongly suggests that capsaicin does not 
directly affect pre-synaptic Ca2+ channels. Other potential off target effects of capsaicin 
also include inhibition of transient (type A) and sustained (delayed rectifier type) voltage 
gated potassium channels in mouse trigeminal ganglion neurons, and these effects of 
capsaicin persisted in TRPV1 knockout mice (Yang et al., 2014). Both type A and delayed 
rectifier potassium currents contribute to regulation of rat HMN firing (Viana et al., 1993),                   
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which was unaltered by capsaicin. However, it remains possible that capsaicin reduces the 
pre-synaptic potassium channel activity through a TRPV1-independent action, and this 
increases glutamatergic release probability. Furthermore, in human embryonic kidney 
(HEK) cells expressing TRPV1, capsaicin inhibited protein synthesis and depolymerized 
microtubules (Han et al., 2007). Additional effects of capsaicin at high doses are direct 
inhibition of  the mitochondrial respiratory chain (Shimomura et al., 1989), significant 
decrease in mitochondrial membrane potential (Dedov et al., 2001), and actions as 
mitochondrial inhibitors to activate apoptosis and/or necrosis (Dedov et al., 2001). 
It was interesting to note that capsazepine alone had significant effects; it 
decreased sEPSC amplitude, indicating that there might be tonic activation of TRPV1 
channels, or that there are non-specific actions of capsazepine (Yamamura et al., 2004). 
Another interesting finding was that sEPSC half-width was significantly increased by 
capsaicin in the presence of capsazepine, an effect that was not observed following 
capsaicin application alone. To address this issue, we tested the effect of another TRPV1 
antagonist, SB366791.  As for capsazepine, SB366791 did not block the effect of 
capsaicin on sEPSC frequency; however, SB366791 did block the change in sEPSC 
amplitude and in Iholding. No changes were observed on any of the sEPSC shape 
parameters after SB366791. It seems likely that any tonic effect on sEPSC amplitude is 
largely by post-synaptic TRPV1 modulation.  
We confirmed this by testing the effect of capsaicin on eEPSCs. Capsaicin did not 
change any eEPSC shape parameters or the eEPSC paired-pulse ratio. Only Iholding was 
altered significantly, consistent with prior results on spontaneous and miniature EPSCs. 
We note that there is a scattered population of TRPV1 positive interneurons in the reticular 
formation (Mezey et al., 2000), raising the possibility that our electrical simulation protocol 
failed to activate these TRPV1-sensitive neurons.  
The negative shift in baseline holding current (Iholding) elicited by capsaicin might 
alter HMN intrinsic excitability and action potential firing rate. We thus tested whether 
capsaicin altered repetitive action potential (AP) firing by HMNs. Capsaicin did not affect 
repetitive firing in HMNs nor were there any changes in action potential shape parameters. 
These results indicate that capsaicin does not strongly modulate motor neuron intrinsic 
excitability.  
Both capsazepine and SB366791 blocked the increase in sEPSC amplitude elicited 
by capsaicin, indicating that this effect of capsaicin is mediated by TRPV1 activation. 
Noxious peripheral stimulation causes rapid translocation of GluR1-containing AMPA 
receptors to the cell membrane (Galan et al., 2004; Larsson & Broman, 2008) and 
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phosphorylation of GluR1 subunits (Fang et al., 2003a; Fang et al., 2003b), suggesting 
possible mechanisms driving increases in sEPSC amplitude. However, increased sEPSC 
and mEPSC frequency after capsaicin were not blocked by prior application of TRPV1 
antagonists, ruling out a role for TRPV1 in this effect. 
In conclusion, our hypothesis that a neuroactive steroid like alfaxalone might 
directly modulate the activity of specific or several TRP channels situated in the plasma 
membrane of motor neurons to bring about a change in Iholding was not supported by the 
present study. Although capsaicin, a classical TRPV1 agonist, significantly increased the 
Iholding this effect is more likely due to an increase in glutamate release and not a direct 
effect on TRPV1. This conclusion is also highlighted by the fact that it took around 8-14 
min for capsaicin to show its effect on excitatory synaptic transmission. Finally, we show 
that capsaicin significantly increased glutamatergic synaptic transmission to HMNs and 
caused a change in Iholding. However, this effect of capsaicin was not sufficient to change 
the intrinsic excitability of HMNs. We also show that these effects of capsaicin are largely 
not mediated by classic TRPV1 activation. This study adds to our present understanding of 
mechanism of action of capsaicin in central neurons and the possibility of non-TRPV1-
mediated effects of capsaicin.   
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Chapter 4 
Capsaicin, a TRPV1 agonist reduces glycinergic inhibitory synaptic transmission to 
rat hypoglossal motor neurons (HMNs) 
Abstract 
Our observations that sEPSC and mEPSC frequency was consistently increased by 
capsaicin application raised the question of whether this effect was specific to excitatory 
glutamatergic presynaptic terminals. As capsaicin has already shown to strongly increase 
spontaneous inhibitory post-synaptic current (sIPSC) frequency and amplitude in spinal 
neurons, we decided to investigate whether capsaicin can also regulate inhibitory synaptic 
transmission to HMNs. Glycinergic IPSCs to HMNs were recorded after pharmacological 
isolation by perfusing brainstem slices with a cocktail of NBQX (10µM), APV (50µM) and 
bicuculline (5µM). Interestingly, capsaicin significantly decreased sIPSC amplitude without 
changing the frequency, indicating a post-synaptic mechanism of action. The amplitude of 
miniature inhibitory post-synaptic currents (mIPSCs), recorded in the presence of 
tetrodotoxin (TTX), was also reduced by capsaicin, without changing mIPSC frequency, 
consistent with a post-synaptic mechanism of action. No significant change in membrane 
current (Iholding) was recorded by capsaicin under both recording conditions, however there 
was a trend towards an outward shift in holding current during sIPSC recordings. The 
effect of capsaicin on inhibitory synaptic transmission also remained unchanged in the 
presence of the TRPV1 antagonist, capsazepine, suggesting that capsaicin acts to reduce 
IPSCs via a mechanism that does not require TRPV1 activation. Here we also show that 
capsaicin reduces glycinergic inhibitory synaptic transmission in HMNs by a post-synaptic 
mechanism. These results expand our understanding regarding the extent to which 
capsaicin can modulate inhibitory synaptic transmission to central neurons. 
 
Introduction 
Our studies on hypoglossal motor neurons after capsaicin application showed a 
very robust increase in excitatory glutamatergic synaptic neurotransmission (Chapter 3). 
However, HMNs not only receive excitatory (serotonergic/noradrenergic) but also inhibitory 
inputs from different brain regions. HMN somata and dendrites receive both glycinergic as 
well as GABAergic synaptic terminals (Aldes et al., 1988). Furthermore, HMNs also 
receive strong inhibitory inputs, predominantly mediated by glycinergic neurotransmission 
(Umemiya & Berger, 1995; Singer et al., 1998; Donato & Nistri, 2000; Singer & Berger, 
2000), making this a good model system to study glycinergic neurotransmission. 
Considering this, we became interested in investigating if capsaicin also modulates 
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inhibitory glycinergic transmission to HMNs, along with increasing glutamatergic 
transmission.  
Interestingly, prior reports have suggested varying degrees of modulation of 
inhibitory transmission to central neurons by capsaicin. For example, Xu and Smith have 
reported an increase in inhibitory currents to neurons of the dorsal motor nucleus of the 
vagus (Xu & Smith, 2015). However, in substantia gelatinosa, capsaicin facilitated 
excitatory without altering inhibitory synaptic transmission (Yang et al., 1998). HMNs 
receive several direct and indirect inputs from different brain structures like locus 
coeruleus (McBride & Sutin, 1976), reticular formation (Rekling et al., 2000), raphe nuclei 
(Manaker & Tischler, 1993), nucleus tractus solitarius (NTS) and area postrema. 
Interestingly, NTS and area posterma receive pulmonary and airway vagal afferents 
(Beaumont et al., 2017), which show expression of the TRPV1 receptors (Doyle et al., 
2002; Hermes et al., 2016). Although, TRPV1 expression is reported in several brain 
structures, including cortex, dentate gyrus, hypothalamus, thalamus, trigeminal 
somatosensory neurons and spinal cord (Mezey et al., 2000; Roberts et al., 2004; 
Cavanaugh et al., 2011), no TRPV1 expression has been reported in the hypoglossal 
motor nucleus. Hence, it becomes an intriguing question to investigate if capsaicin, which 
is classically known to activate TRPV1 receptors, affects the inhibitory synaptic 
transmission to HMNs. The aim of this study was to investigate the actions of capsaicin on 
spontaneous inhibitory glycinergic synaptic transmission to HMNs in the neonatal rat 
brainstem slices. 
 
Results 
Capsaicin (10µM) reduces spontaneous glycinergic inhibitory post-synaptic current 
(sIPSC) amplitude to rat hypoglossal motor neurons (HMNs) 
The effects of capsaicin on several central and peripheral neuronal types have been 
already studied to varying degrees. However, the effects of capsaicin on inhibitory synaptic 
transmission to HMNs remain uninvestigated. This was particularly important, as we have 
already reported an increase in excitatory synaptic transmission by capsaicin (Chapter 3). 
The possibility of dual modulation of inhibitory as well as excitatory synaptic transmission 
to HMNs by capsaicin led us to investigate this effect.     
During the capsaicin application period (10µM, 9-11min) mean sIPSC amplitude 
showed a significant reduction from -74.7 to -27.9pA (-63% change from control. 
p=0.0009, n=11, Figure 4.1D and E, Table 4.1). Similarly, there was also a significant 
decrease in sIPSC half-width from 10.8 to 5.9ms (-45% change from control, p=0.0009, 
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n=11, Figure 4.1H, Table 4.1). However, this effect was not associated with any significant 
change in the frequency of sIPSCs (Figure 4.1B and C). Figure 4.1F and G show the 
distribution of sIPSC amplitudes and inter-event intervals in control and capsaicin 
conditions respectively. The amplitude and inter-event interval distribution shows a 
significant shift toward low amplitude and low frequency events respectively (Kolmogorov-
Smirnov test). No change was observed in sIPSC 10–90% rise time (Figure 4.1I) and 
baseline holding current (Iholding) (Figure 4.1J). It was interesting to note that although the 
change in Iholding was not significant, it shifted toward more positive levels, opposite to the 
change observed during recordings of sEPSCs. 
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Figure 4.1 10µM Capsaicin (Caps) reduces glycinergic inhibitory post-synaptic 
current amplitude to rat HMNs. 
(A) A time line of the experimental protocol. After baseline control recording, slices were 
superfused with capsaicin (10µM) dissolved in aCSF for 9-11min before recording the 
effect of capsaicin on spontaneous inhibitory post-synaptic currents (sIPSCs). (B) 
Representative sIPSC traces recorded in (control) and in 10µM capsaicin from HMNs 
voltage-clamped at -60 mV. (C) Mean spontaneous IPSC frequency during control and 
capsaicin conditions, showing no significant change in frequency with capsaicin. (D) 
Representative averaged amplitude traces of spontaneous IPSCs before (control) and 
during capsaicin. (E) Mean spontaneous IPSC amplitude during control and capsaicin, 
showing a significant decrease in amplitude with capsaicin. Averaged cumulative 
frequency distribution of sIPSC amplitude (F) and inter-event interval (G). Kolmogorov-
Smirnov test to amplitude and inter-event interval showed a significant difference between 
control and capsaicin conditions. Mean sIPSC half-width (H) also showed a significant 
reduction after capsaicin application. Rise time (I) and baseline holding current (Iholding) (J) 
remain unchanged after capsaicin application. All recordings were made with NBQX 
(10µM), APV (50µM) and bicuculline (5µM). Data represented as mean ± S.D. for n=11 
cells, each from separate brain slice. Significance is shown as ***p<0.001. A paired two-
tailed t-test was used to determine whether the difference between data points under 
control and capsaicin conditions was statistically significant. 
 
Table 4.1 Spontaneous IPSC parameters of neonatal rat HMNs upon application of 
10µM capsaicin. 
Parameter Control 10µM Caps Statistical 
Significance Mean ±SD n Mean ±SD n 
Amplitude (pA) -74.7 39.4 11 -27.9 11.1 11 *** p=0.0009 
Half-width (ms) 10.8 4.2 11 5.9 1.7 11 *** p=0.0009 
Rise time (ms) 3.0 1.5 11 3.1 1.4 11 ns, p=0.8 
Frequency (Hz) 1.37 0.2 11 1.26 0.6 11 ns, p=0.57 
Iholding (pA) -122.3 66.6 11 -93.18 36.5 11 ns, p=0.067 
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Capsaicin acts via a TTX-insensitive mechanism to reduce amplitude of glycinergic 
inhibitory currents in rat hypoglossal motor neurons (HMNs) 
Reduction of sIPSC amplitude is consistent with a postsynaptic reduction in 
glycinergic currents; however, it is also possible that it could be due to a reduction in 
presynaptic glycine release. Hence, to further differentiate between these possible 
mechanisms underlying the effect of capsaicin on inhibitory synaptic transmission, 
miniature IPSCs (mIPSCs) were analysed where, in addition to NBQX, APV and 
bicuculline, 1µM tetrodotoxin (TTX) was added for complete blockage of action potentials 
(Figure 4.2B). During the capsaicin application period (10µM, 4-6min), mean mIPSC 
amplitude still showed a significant decrease from -57.8 to -25.6pA (-56% from control, 
p=0.05, n=7, Figure 4.2D and E, Table 4.2). The effect of capsaicin on half-width in 
presence of TTX also persisted and showed a significant reduction from 9.3 to 5.2ms (-
44% from control, p=0.025, n=7, Figure 4.2H, Table 4.2). Figure 4.2F and G show the 
distribution of mIPSC amplitudes and inter-event intervals in control and capsaicin 
conditions. The amplitude and inter-event interval distribution shows a significant shift 
toward low amplitude and low frequency events respectively (Kolmogorov-Smirnov test). 
Similar to sIPSCs, no significant changes were observed in mIPSC 10–90% rise time 
(Figure 4.2I) and baseline holding current (Iholding) (Figure 4.2J). 
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Figure 4.2 10µM Capsaicin (Caps) reduces miniature inhibitory post-synaptic 
current amplitude to rat HMNs. 
(A) A time line of the experimental protocol. After baseline control recording, slices were 
superfused with capsaicin (10µM) dissolved in aCSF for 4-6min before recording the effect 
of capsaicin on miniature inhibitory post-synaptic currents (mIPSCs). (B) Representative 
mIPSC frequency trace recorded under control and in presence of 10µM capsaicin from 
HMNs voltage-clamped at -60mV. (C) Mean mIPSC frequency under control and capsaicin 
conditions showing no significant change in frequency. (D) Representative mIPSC 
amplitude trace showing a significant decrease after capsaicin application. (E) Mean 
mIPSC amplitude significantly reduced after capsaicin. Averaged cumulative frequency 
distribution of mIPSC amplitude (F) and inter-event interval (G). Kolmogorov-Smirnov test 
to amplitude and inter-event interval showed a significant difference between control and 
capsaicin conditions. Mean mIPSC half-width (H) also showed a significant reduction 
under capsaicin condition. Rise time (I) and baseline holding current (Iholding) (J) remain 
unchanged after capsaicin application. All recordings were made with NBQX (10µM), APV 
(50µM), bicuculline (5µM) and 1µM tetrodotoxin (TTX). Data represented as mean ± S.D. 
for n=7 cells, each from separate brain slice. Significance is shown as *p<0.05. A paired 
two-tailed t-test was used to determine whether the difference between data points under 
control and capsaicin conditions was statistically significant. 
 
Table 4.2 Miniature IPSC parameters of neonatal rat HMNs upon application of 10µM 
capsaicin. 
Parameter Control 10µM Caps Statistical 
Significance Mean ±SD n Mean ±SD n 
Amplitude (pA) -57.8 38.9 7 -25.6 5.4 7 *p=0.05 
Half-width (ms) 9.3 3.6 7 5.2 1.1 7 *p=0.025 
Rise time (ms) 3.02 1.4 7 2.8 0.63 7 ns, p=0.7 
Frequency (Hz) 1.56 0.38 7 1.05 0.39 7 ns, p=0.11 
Iholding (pA) -142.2 105.5 7 -133.4 133 7 ns, p=0.5 
 
The TRPV1 antagonist, capsazepine does not block the effect of capsaicin on sIPSC 
amplitude 
Several reports suggest that the effects of capsaicin application on central neurons 
is via TRPV1 receptors, as capsaicin effects were successfully blocked by capsazepine 
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(Savidge et al., 2001; Zschenderlein et al., 2011). However, our studies on glutamatergic 
excitatory synaptic transmission show that TRPV1 activation is not involved in the actions 
of capsaicin (Chapter 3). This led us to investigate if the effect of capsaicin on glycinergic 
inhibitory transmission is also independent of TRPV1 activation.  
Application of capsaicin (10µM, 4-10min) in the presence of capsazepine still 
showed a reduction in sIPSC amplitude (-46% from control, p=0.0016, n=8, Figure 4.3D 
and E, Table 4.3). It was interesting to note that only in the presence of capsazepine, 
capsaicin also showed a significant reduction in sIPSC frequency (-40% from control, 
p=0.044, n=8, Figure 4.3B and C, Table 4.3), which was not observed when capsaicin was 
applied alone (Figure 4.1 and 4.2). Figure 4.3F and G show the distribution of mIPSC 
amplitudes and inter-event intervals in control and capsaicin conditions. The amplitude and 
inter-event interval distribution shows a significant shift toward low amplitude and low 
frequency events respectively when tested for control and capsaicin condition 
(Kolmogorov-Smirnov test). Capsazepine interestingly blocked the effect of capsaicin on 
sIPSC half-width (Figure 4.3H). No changes were observed in 10-90% rise time (Figure 
4.3I) and baseline holding current (Iholding) (Figure 4.3J). Capsazepine alone did not have a 
significant change in either of the parameters tested; however, there was a trend towards 
lower frequency and amplitude events.   
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Figure 4.3 Pre-application of the TRPV1 antagonist, capsazepine (Capz) failed to 
block the effect of capsaicin (Caps) on sIPSC amplitude. 
(A) Experimental protocol timing. After recording baseline control activity, slices were 
superfused with capsazepine (Capz, 10µM) in aCSF for 5min before recording 
capsazepine-induced changes in sIPSCs. Capsaicin (10µM) in aCSF was added for 4-
10min after which capsaicin induced sIPSC responses were recorded. Representative 
traces for sIPSC frequency (B) under control, capsazepine and capsaicin conditions. (C) 
Averaged frequency plot showing significant decrease after capsaicin application in 
presence of capsazepine. (D) Representative amplitude for sIPSC frequency under all 3 
conditions. (E) Mean amplitude plot showing significant reduction after capsaicin. 
Averaged cumulative frequency distribution plots of sIPSC amplitude (F) and inter-event 
interval (G). Kolmogorov-Smirnov test shows significant difference between control and 
capsaicin condition in both plots. Mean sIPSC half-width (H), rise time (I) and baseline 
holding current (Iholding) (J) were unaffected under both conditions. All recordings were 
made in the presence of NBQX (10µM), APV (50µM) and bicuculline (5µM). Data 
represented as mean ± S.D. for n=8 cells, each from a separate brain slice. Significance is 
shown as *p<0.05, **p<0.01. A paired two-tailed t-test was used to determine whether the 
difference between data points under control, capsazepine and capsaicin + capsazepine 
conditions was statistically significant. 
 
Table 4.3 Spontaneous IPSC parameters of neonatal rat HMNs upon application of 
10µM capsaicin in presence of capsazepine. 
Parameter Control 10µM Capz 10µM Caps 
Mean ±SD n Mean ±SD n Mean ±SD n 
Amplitude (pA) -50.5 15.7 8 -45.8 15.4 8 -27.4 8.3 8 
Half-width (ms) 6.2 2.9 8 6.4 3.2 8 5.3 2.6 8 
Rise time (ms) 2.1 1.1 8 2.4 1.2 8 2.8 1.2 8 
Frequency (Hz) 2.21 0.94 8 1.65 0.78 8 1.33 0.81 8 
Iholding (pA) -168 113 8 -226.2 286.5 8 -214 275.3 8 
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Parameter Statistical Significance 
Control vs 10µM Capz 
Statistical Significance 
Control vs 10µM Caps 
Amplitude (pA) ns, p=0.39 **p=0.0016 
Half-width (ms) ns, p=0.66 ns, p=0.42 
Rise time (ms) ns, p=0.093 ns, p=0.11 
Frequency (Hz) ns, p=0.62 *p=0.044 
Iholding (pA) ns, p=0.41 ns, p=0.49 
 
Discussion 
This study was aimed at determining whether capsaicin also modulates inhibitory 
glycinergic synaptic transmission to rat HMNs, as along with glutamatergic (O'Brien et al., 
1997; Del Caño et al., 1999), they also receive strong glycinergic inputs (Singer et al., 
1998; Donato & Nistri, 2000). In contrast to its effects on sEPSCs, capsaicin selectively 
and significantly decreased sIPSCs amplitude and half-width, without altering sIPSC 
frequency. It was intriguing to note that Iholding was not significant altered, and indeed 
tended to shift toward more positive value, opposite of the significant negative shift 
observed when sEPSCs were recorded. This result suggests that capsaicin significantly 
reduces glycinergic inhibitory synaptic transmission to rat HMNs by a post-synaptic 
mechanism of action.  
We further tested if this activity is dependent on action potential mediated release of 
inhibitory neurotransmitter. We observed that the effect of capsaicin on glycinergic 
transmission is not dependent on spontaneous action potential generation, as there was a 
significant decrease in mIPSC amplitude even in presence of TTX. As action potential-
independent miniature currents and action potential-dependent currents constitute the sum 
of spontaneous synaptic currents, we conclude that the decrease in sIPSC amplitude is 
due to a decrease in mIPSC amplitude.  
Prior slice electrophysiology studies investigating capsaicin and its effect on 
inhibitory transmission to central neurons have reported varying effects, with different 
mechanisms of action. Study on dorsal motor nucleus of the vagus by Xu and Smith show 
an increase in inhibitory current frequency (Xu & Smith, 2015). On the other hand, 
capsaicin facilitated excitatory but not inhibitory transmission in substantia gelatinosa 
neurons (Yang et al., 1998). Similarly, a study performed on mouse spinal neurons, a 
model system closer to the one used in the present study (brainstem neurons) showed an 
increase in sIPSC frequency and attributed this effect to the activation of pre-synaptic 
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inhibitory interneurons (Ferrini et al., 2007). These results differ to our conclusions that 
capsaicin acts via a postsynaptic modulation of glycine channel activity or conductance, 
with little pre-synaptic effect, as observed from its effect on sIPSCs and mIPSC amplitude. 
Although not significant, capsaicin did tend to elicit an outward current during sIPSC 
recordings (Figure 4.1) and showed no effect in other conditions tested (Figure 4.2 and 
4.3).  This stands in contrast to the consistent and significant inward current elicited by 
capsaicin when recording sEPSCs and mEPSCs. As capsaicin was reducing inhibitory 
glycinergic membrane conductance, we would expect that this would produce a net inward 
current, so the absence of such an effect lends support to the hypothesis that the inward 
current seen during excitatory transmission experiments was primarily due to increased 
excitatory glutamatergic membrane conductance. However, further investigation of this 
effect is needed to underpin this hypothesis. 
Finally, we tested whether the effect of capsaicin can be blocked by pre-application 
of a competitive antagonist of TRPV1 receptors, capsazepine (Bevan et al., 1992). Our 
results show that pre-application of capsazepine did not block the effect of capsaicin on 
sIPSC amplitude, however, the effect on sIPSC half-width was blocked. It was also 
observed that sIPSC frequency was significantly reduced in presence of capsazepine. 
However, it was interesting to note that capsazepine alone, did not show any significant 
changes to any of the shape parameters tested, which shows that there is no tonic TRPV1 
activity affecting inhibitory glycinergic transmission. This is contrary to the observation that 
capsazepine did exhibit a tonic effect on excitatory glutamatergic recordings, as shown by 
a change in sEPSC amplitude under capsazepine alone condition.  A possible reason for 
this reduction in frequency can be attributed to the fact that at concentrations required to 
observe the antagonistic activity of capsazepine (~5-10µM), it can modulate several other 
ion channels and receptors, including voltage-activated calcium channels (Docherty et al., 
1997) and nicotinic acetylcholine receptors (Liu & Simon, 1997). The inability of 
capsazepine to block all the effects of capsaicin emphasizes capsaicin’s off-target effects. 
Capsaicin is reported to show off-target effects on several voltage gated channels like 
sodium (Wang et al., 2007), calcium (Köfalvi et al., 2006) and potassium (Yang et al., 
2014). As miniature recordings were performed in presence of TTX, we can safely 
conclude that capsaicin do not act on voltage gated sodium channels. However, a direct 
modulation of calcium and/or potassium channels remains a possibility. Furthermore, an 
inhibition of mitochondrial respiratory chain (Shimomura et al., 1989) and decrease in 
mitochondrial membrane potential (Dedov et al., 2001) are also reported. It is very well 
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possible that capsaicin in present study either acted on one or more of the above targets 
which were not specifically studied here. 
In conclusion, this study shows for the first time that capsaicin, a classic TRPV1 
agonist, reduces inhibitory glycinergic synaptic transmission to rat HMNs. Since this effect 
was TTX-insensitive, we also conclude that this effect is independent of action potential 
generation and is possibly mediated via a post-synaptic mechanism. Finally, we have also 
show that this inhibitory effect of capsaicin is mediated via a mechanism other than 
activation of classic TRPV1 receptors.   
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Chapter 5 
Alfaxalone and capsaicin do not show any species-related difference in their effect 
on neonatal C57/BL6 WT mouse HMNs  
Abstract 
Our studies on rat hypoglossal motor neurons showed significant modulation of 
inhibitory glycinergic and excitatory glutamatergic synaptic transmission following 
application of alfaxalone and capsaicin respectively. However, both alfaxalone-like steroid 
molecules and several TRP channel agonists can have species, age and gender related 
differences in their effects. We conducted a study to gauge the possibility of species 
differences in the effects of alfaxalone and capsaicin on inhibitory and excitatory synaptic 
transmission to HMNs in brainstem slice preparations. Wild type C57/BL6 mice HMNs 
were studied using similar conditions used for rat HMN recordings. Our results show that 
alfaxalone significantly reduced sIPSC amplitude (-38%) and half-width (-19%) along with 
frequency (-20%) in mouse HMNs. It was interesting to note that there was no significant 
change in the baseline holding current (Iholding) upon alfaxalone treatment. On the other 
hand, capsaicin application showed a significant increase in amplitude (+25%) and 
frequency (+118%) of sEPSCs to mouse HMNs. Similar to the effect seen in our rat study, 
a significant negative shift in the baseline holding current (Iholding) (-90%) was observed 
after capsaicin application. Our results show that, in mouse HMNs, alfaxalone reduces 
spontaneous glycinergic neurotransmission and capsaicin enhances spontaneous 
glutamatergic neurotransmission. From these results, we conclude that there is unlikely to 
be a significant species difference in the effect of either alfaxalone or capsaicin on HMNs.  
 
Introduction 
Steroids or steroid-like molecules and several TRP channel modulators are 
implicated in modulating various neuronal functions (Zakon, 1998; Moran et al., 2004). In 
particular, steroids can regulate a variety of functions in central neurons by acting either on 
membrane or intracellular steroid receptors to bring about both fast and delayed effects 
(Joëls, 1997). Electrophysiological studies show that steroids can potentially alter the 
electrical excitability of neuronal membranes and thereby cause changes in firing 
properties (Okuhara & Beck, 1998; Pielecka et al., 2006). These effects are not limited to 
endogenously synthetised steroids (neurosteroids), such as	 progesterone and its 
metabolites allopregnanolone (Robichaud & Debonnel, 2004), but have also exhibited by 
synthetic steroid molecules like ganaxolone (Robichaud & Debonnel, 2006), alfaxalone 
(Ahrens et al., 2008). 
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However, an interesting phenomenon is the variation in steroid effects based on sex 
or species of animals tested. Secretion of testosterone in male rodents is a major 
differentiation factor resulting in differences in physiology and behaviour between male 
and female rodents (Bonthuis et al., 2010). Significant sex differences in responses to 
steroid treatments are reported (Alele & Devaud, 2007), most likely due to the variation in 
the basal levels of endogenous steroids between the two groups. For example, differences 
in the sedative effects of allopregnanolone were observed between male and female rats 
(Irwin et al., 2014). An important determinant in the variability of effects is attributed to 
differences in the steroid metabolising enzymes in the liver. CYP2C12 is one of the 
isoforms of the cytochrome P450 (CYP2) enzyme involved in hydroxylation of steroids and 
is highly expressed in the livers of adult female rats compared to males (Martignoni et al., 
2006). Similarly, CYP2C11 levels are dramatically induced at puberty in male, but not 
female, rats (Martignoni et al., 2006).    
On the other hand, there is considerable support in the literature for significant 
species-related differences between rats and mice. These differences can either be 
generated within the species e.g. genetic mutation within a closed colony (Egan et al., 
2007) or can also be due to variation in breeding protocols (Bonthuis et al., 2010). 
Species-related differences can also be observed because of naturally occurring 
anatomical variations which can lead to striking differences in adult life. For example, in 
the preoptic area, steroidal modulation of neuronal nitric oxide synthases (nNOS) 
expression is opposite in rats and mice. In rats, androgens acting via androgen receptors 
bring about an increase in nNOS levels. However, in mice, an opposite effect is observed 
where estrogens acting via estrogen receptors increase nNOS expression (Bonthuis et al., 
2010). Another prominent difference between rats and mice is in the expression of the 
protein calbindin in the sexually dimorphic nucleus (SDN). In rats, a lower 
immunoreactivity is observed at birth and further increases post-natally. However, in mice, 
the expression is high pre-natally (Bonthuis et al., 2010). 
Studies on neuroanatomical markers in the brains of rats and mice have also 
demonstrated species differences (Bonthuis et al., 2010). As for sex-related differences, 
the majority of species-related differences between rats and mice arise because of 
differences in enzyme catalytic activity and metabolic clearance. Particularly with steroids, 
species differences are reported owing to a significant difference in metabolising enzymes 
in liver (Busso & Ruiz, 2011).  
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Taken together, prior studies have reported sex and species differences in the 
effects of steroids and it thus becomes important to investigate if alfaxalone, a synthetic 
neuroactive steroid, shows any species-related variation in its effects on mouse HMNs.   
It is interesting to note that considerable species-related differences exist for the 
effect of capsaicin (Szallasi & Blumberg, 1999). Age-, strain- and species-related 
differences in sensitivity to capsaicin is extensively reported in previous studies. For 
example, cell bodies of primary sensory neurons are more susceptible to capsaicin in 
newborn than in adult rats, as concluded from the study that showed complete impairment 
versus partial recovery after capsaicin treatment in newborn and adult rats respectively 
(Jancso et al., 1977). Amphibians (toads) show low sensitivity to capsaicin (Hawkins et al., 
1991) when compared to rats. Similarly, a significant difference in the amino acid 
sequence homology is observed between avian and mammalian capsaicin receptors 
(Jordt & Julius, 2002). The human hTRPV1 channel is harder to open and hence, the 
efficacy of capsaicin as a TRPV1 agonist is lower for the human receptor than the rat 
receptor (Wang et al., 2010). Measurement of compound action potentials in the 
saphenous nerve show low sensitivity to capsaicin in guinea-pig and rabbit when 
compared to rats (Baranowski et al., 1986).  
Considering this variability in the effects of capsaicin, we became interested in 
investigating if there are any species-related differences between rat and mice, in 
comparing the effects of capsaicin on spontaneous excitatory currents in mouse HMNs.  
 
Results  
Alfaxalone (25µM) reduces spontaneous glycinergic IPSC amplitude, half-width and 
frequency in mouse hypoglossal motor neurons (HMNs) 
Our earlier investigation on the effect of alfaxalone on IPSCs (Chapter 2) to rat 
HMNs had shown a significant reduction in amplitude and frequency of glycinergic 
inhibitory currents, which was accompanied by a positive outward shift in the baseline 
holding current (Iholding). However, no study has investigate if alfaxalone affects glycinergic 
inhibitory synaptic transmission to mouse HMNs. To check if there is any species related 
variation in the effect of alfaxalone when tested on C57/BL6 mice, a similar experiment 
was designed with same internal solutions and pharmacological blockers of GABAergic 
and glutamatergic synaptic transmission, NBQX (10µM), APV (50µM) and bicuculline 
(5µM).  
Mean sIPSC amplitude was significantly reduced from -62.7 to -39.2pA (-38% 
change from control, p=0.003, n=12, Figure 5.1E, Table 5.1). Representative amplitude 
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traces (Figure 5.1 D) shows a reduction with alfaxalone. There was also a significant 
reduction in the half-width of sIPSCs from 9.6 to 7.8ms (-19% change from control, 
p=0.001, n=12, Figure 5.1H, Table 5.1). Similarly, a significant decrease was also 
observed in sIPSC frequency from 1.98 to 1.59Hz (-20% change from control, p=0.041, 
n=12, Figure 5.1C, Table 5.1). A representative frequency trace under control and 
alfaxalone conditions (Figure 5.1B) show the reduction in sIPSC frequency. The 
distribution of sIPSC amplitudes and inter-event intervals in control and alfaxalone 
conditions are shown in Figure 5.1F, G.  A Kolmogorov-Smirnov test applied to the 
amplitude and inter-event interval distribution shows a significant shift toward low 
amplitude and high frequency events respectively. Figure 2.1I show no change in sIPSC 
10–90% rise time after alfaxalone application. It was interesting to note that baseline 
holding current (Iholding) showed no significant change in either direction in presence of 
alfaxalone which differs from our results in rat HMNs. These results suggest that 
alfaxalone causes a reduction in inhibitory glycinergic synaptic transmission to mouse 
HMNs. Similarly, a robust decrease in both frequency and amplitude of sIPSCs show a 
possible pre- and post-synaptic mechanism similar to observations in rat HMNs.   
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Figure 5.1 Alfaxalone (Alfa) reduces spontaneous inhibitory post-synaptic 
transmission to WT C57BL/6 mouse HMNs. 
(A) A time line of the experimental protocol. After baseline control recording, slices were 
superfused with alfaxalone (25µM) dissolved in aCSF for 2-4min before recording the 
effect of alfaxalone on spontaneous inhibitory post-synaptic currents (sIPSCs). (B) 
Representative sIPSC frequency trace recorded under control and in presence of 25µM 
alfaxalone from HMNs voltage-clamped at -60mV. (C) Mean sIPSC frequency under 
control and alfaxalone conditions showing a significant decrease in frequency with 
alfaxalone. (D) Representative sIPSC amplitude showing a significant decrease after 
alfaxalone application. (E) Mean sIPSC amplitude significantly reduced after alfaxalone. 
Averaged cumulative frequency distribution of sIPSC amplitude (F) and inter-event interval 
(G). Kolmogorov-Smirnov test to amplitude and inter-event interval showed a significant 
difference between control and alfaxalone conditions. Mean sIPSC half-width (H) rise time 
(I) and baseline holding current (Iholding) (J) remain unchanged after alfaxalone application. 
All recordings were made with NBQX (10µM), APV (50µM) and bicuculline (5µM). Data 
represented as mean ± S.D. for n=12 cells, each from separate brain slice. Significance is 
shown as *p<0.05, **p<0.01. A paired two-tailed t-test was used to determine whether the 
difference between data points under control and alfaxalone conditions was statistically 
significant. 
 
Table 5.1 Spontaneous IPSC parameters of neonatal C57BL/6 WT mice HMNs upon 
application of 25µM alfaxalone. 
 
Parameter 
Control 25µM Alfa Statistical 
Significance Mean ±SD n Mean ±SD n 
Amplitude (pA) -62.7 37.08 12 -39.2 23.4 12 ** p=0.003 
Half-width (ms) 9.6 4.5 12 7.8 3.5 12 ** p=0.001 
Rise time (ms) 2.7 1.7 12 3.5 2.2 12 ns, p=0.064 
Frequency (Hz) 1.98 0.76 12 1.59 0.91 12 * p=0.041 
Iholding (pA) -173 159.7 12 -171.3 192.6 12 ns, p=0.93 
 
Capsaicin (10µM) increases spontaneous excitatory post-synaptic current (sEPSC) 
frequency and amplitude to mouse hypoglossal motor neurons (HMNs) 
Our results in Chapter 3 had clearly shown a significant positive modulation of 
sEPSCs in rat HMNs at two different concentrations of capsaicin (1 and 10µM). However, 
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to our knowledge, the effect of capsaicin on spontaneous excitatory currents in mouse 
HMNs are yet to be reported. Similarly, considering the fact that there is significant species 
related variation in sensitivity of capsaicin, we decided to investigate if capsaicin shows 
any species difference when tested on C57/BL6 mice. As previous studies on capsaicin 
effects in mice (Güler et al., 2012) show robust effects in slice electrophysiology when 
capsaicin was used at 10µM, we decided to use this higher dose for our studies on 
spontaneous glutamatergic excitatory currents.  
After capsaicin application (7-11 min, 10µM), it was noted that there is a significant 
increase in sEPSC frequency and amplitude (Figure 5.2 B-G). An increase in frequency is 
represented in Figure 5.2B where an increase in the number of negative going excitatory 
events is observed under capsaicin condition. Figure 5.2C shows an increase in mean 
sEPSC frequency from 2.02 to 4.39Hz (+118% of control, p=0.03; n=8; Table 5.2). Figure 
5.2D represents sEPSC amplitude under both conditions. An increase in mean sEPSC 
amplitude from -18.1 to -22.6pA is shown in Figure 5.2E (+25% increase from control, 
p=0.021, n=8, Table 5.2). Figure 5.2F and G showing distribution of amplitude and inter-
event interval under control and capsaicin conditions. A Kolmogorov-Smirnov test applied 
to the inter-event interval distribution shows a significant shift high frequency events. Other 
sEPSC shape parameters, such as half-width (Fig 5.2H) and 10-90% rise time (Fig 5.2I) 
remained unchanged during capsaicin application. However, baseline holding current 
(Iholding), showed a significant inward shift from -60.4 to -114.9pA (+90% of control, 
p=0.011, n=8, Fig 5.2J).     
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Figure 5.2 Capsaicin (Caps) increases glutamatergic excitatory post-synaptic 
current frequency and amplitude to mouse HMNs. 
(A) A time line of the experimental protocol. After baseline control recording, slices were 
superfused with capsaicin (10µM) dissolved in aCSF for 7-11min before recording the 
effect of capsaicin (Caps) on spontaneous excitatory post-synaptic currents (sEPSCs). (B) 
Representative sEPSC traces recorded in the absence (control) and presence of 10µM 
capsaicin from a HMN voltage-clamped at -60mV. (C) Mean sEPSC frequency showing a 
significant increase during control vs capsaicin conditions. (D) Representative averaged 
amplitude traces under control and capsaicin conditions. (E) Mean sEPSC amplitude plot 
showing a significant increase in sEPSC amplitude with capsaicin. Averaged, cumulative 
frequency distribution plots of sEPSC amplitude (F) and inter-event interval (G). 
Kolmogorov-Smirnov test of inter-event interval shows a significant difference between 
control and capsaicin conditions. Mean sEPSC half-width (H) and rise time (I) did not 
change after capsaicin application. (J) Baseline holding current (Iholding) was significantly 
altered in inward direction by capsaicin. All recordings were made in the presence of 20µM 
strychnine HCl. Data represented as mean ± S.D. for n=8 cells, each from a separate brain 
slice. Significance is shown as *p<0.05. A paired two-tailed t-test was used to determine 
whether the difference between data points under control and capsaicin conditions was 
statistically significant. 
 
Table 5.2 Spontaneous EPSC parameters of neonatal C57BL/6 WT mice HMNs upon 
application of 10µM capsaicin. 
 
Parameter 
Control 10µM Caps Statistical 
Significance Mean ±SD n Mean ±SD n 
Amplitude (pA) -18.1 4.5 8 -22.6 3.9 8 * p=0.021 
Half-width (ms) 2.2 0.5 8 2.0 0.5 8 ns, p=0.51 
Rise time (ms) 1.6 0.4 8 1.2 0.4 8 ns, p=0.12 
Frequency (Hz) 2.02 0.9 8 4.39 2.79 8 * p=0.03 
Iholding (pA) -60.4 48 8 -114.9 40.2 8 * p=0.011 
 
Discussion 
Our present study was aimed at investigating if any species-related difference in the 
effects of alfaxalone and capsaicin on mouse HMNs exists. Although there is evidence of 
species variation in effects of several steroids and TRP channel modulators, our study did 
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not show any such variation in alfaxalone and capsaicin effects on inhibitory and excitatory 
currents respectively.  
Previously, Lau and colleagues (Lau, 2013) showed that alfaxalone, a synthetic 
neuroactive steroid molecule, reduces spontaneous glycinergic synaptic transmission to 
rat HMNs. We show (Chapter 2) that alfaxalone also significantly reduced miniature 
glycinergic inhibitory synaptic transmission in the same species (Wistar rat). However, 
considering the steroid nature of alfaxalone, it became desirable to check if there is any 
species-related difference in effects of alfaxalone between rats and mice.  
Our results for spontaneous glycinergic currents on mouse HMNs (present work) 
show that, along with reduction in amplitude and frequency, there was also a significant 
decrease in half-width, which is similar to that observed by Lau and colleagues (Lau, 2013) 
in their study of rat HMNs. The same study also showed a significant negative shift in 
Iholding, which was not observed in the present study on mice. The cause for this 
discrepancy remains unidentified and could be attributed to species difference between 
neonatal rats and mice. On the other hand, in our study of the effects of alfaxalone on 
miniature glycinergic currents in rat HMNs, modulation in half-width was not noted, which 
contradicts the effect observed in sIPSCs in mouse study, where a significant decrease in 
half-width was observed. This difference can be attributed to the fact that we only tested 
miniature glycinergic synaptic transmission in rats, which were performed in presence of 
TTX; however, no miniature recordings were performed the mice study. To explore this 
phenomenon further, miniature IPSC recording could be performed on mouse HMNs in the 
presence of alfaxalone.  
Capsaicin, a classical TRPV1 receptor agonist, caused a significant increase in 
glutamatergic synaptic transmission to mouse HMNs, which was evident as an increase in 
both frequency and amplitude of spontaneous synaptic currents. Modulation of both 
frequency and amplitude indicate a possibility of dual pre- and post-synaptic mechanisms 
causing increased glutamate release and enhanced postsynaptic glutamate receptor 
activation. It is also important to note that this effect was also accompanied by a negative 
shift in the baseline holding current (Iholding), which might contribute to modulation of motor 
neuron excitability.  
Comparing the effects of 10µM capsaicin on rat and mouse HMNs show a close 
similarity in the relative effects from control. Increases in amplitude of sEPSCs in rat and 
mouse from control were very similar, +26% and +25% respectively (Table 3.2 and 5.2). 
Similarly, the increase in sEPSC frequency when compared to control was very similar in 
both rat and mouse study (+116% and +118% respectively). This emphasizes the fact that 
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there is unlikely to be significant species related variation in the sensitivity of rat and 
mouse HMNs to capsaicin.   
In conclusion, we report that alfaxalone and capsaicin effects on spontaneous 
inhibitory and excitatory currents respectively did not show significant species-related 
difference between neonatal Wistar rats and C57/BL6 mice.  
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General discussion  
Rational development of a safe and reliable anaesthetic regime for laboratory 
rodents was the over-arching aim of this study. As anaesthetic protocols are widely used in 
biomedical research laboratories, effort in understanding and developing better 
anaesthetics is highly desirable. The present study was aimed at furthering our 
understanding of a well-known anaesthetic agent that is widely used in several large 
animal species, but not in laboratory rodents. We focused on alfaxalone, which is 
successfully used in cats, dogs, horses, etc, with minimal side effects. As alfaxalone is 
associated with a high margin of safety in larger animals, it became important to 
understand if it can provide an effective and safe alternative to current anaesthetics in 
regular laboratory practices for rats and mice. However, severe muscular twitching is 
observed when the same alfaxalone formulation is administered to laboratory rodents. 
Hence, understanding the mechanism underpinning twitching behaviour in rats was the 
primary focus of our study. It was assumed that the severe twitching observed in rats could 
be brought about by modulation of inhibitory as well as excitatory synaptic transmission to 
brain stem motor neurons. As the anaesthetic activity of alfaxalone is attributed to its well 
documented modulation of GABAergic transmission, we focused on glycinergic inhibitory 
and glutamatergic excitatory synaptic transmissions in our study.  
As muscle twitching is most likely driven by motor neuron activity, it was imperative 
to investigate the modulation brought about by alfaxalone at synaptic levels to motor 
neurons. A specialized group of cells in the brain stem, viz. hypoglossal motor neurons 
(HMNs) were selected for this investigation. Electrophysiological recordings were obtained 
from individual motor neurons to study inhibitory and excitatory synaptic transmission to 
HMNs in slice preparations after alfaxalone application.    
First, modulation of miniature inhibitory glycinergic transmission was investigated 
which showed that alfaxalone robustly decreases amplitude and frequency of inhibitory 
currents. We also showed that activity-dependent and -independent excitatory 
glutamatergic transmission and repetitive action potential firing in HMNs is not affected by 
alfaxalone. Hence, our data confirms that alfaxalone selectively reduces glycinergic 
inhibition to rat HMNs, which we believe causes a severe disruption of excitatory-inhibitory 
balance and leads to motor neuron activity and muscular twitching. 
A regular observation after alfaxalone application was the modulation of baseline 
holding current (Iholding), therefore, we investigated the possibility that alfaxalone activated 
either selective or multiple TRP channels that might produce HMN depolarization and an 
increase in intracellular Ca2+ concentration. It can be argued that upon this increase in 
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intracellular Ca2+ from several, yet unidentified secondary signaling pathways, causes 
release of endocannabinoids and/or endovanilloids. This led us to investigate the possible 
modulation of synaptic activity by capsaicin, a TRPV1 agonist.  
Interestingly, capsaicin itself had a strong modulatory role in the synaptic 
neurotransmission to HMNs. We have for the first time shown that capsaicin increases 
excitatory glutamatergic and reduces inhibitory glycinergic synaptic transmission to HMNs 
without affecting the intrinsic excitability. We also show that these effects are not mediated 
by typical TRPV1 activation.  
Although capsaicin did change Iholding, it does not support our hypothesis that 
alfaxalone might bring about this selective modulation of TRPV1 receptors, as we believe 
that modulation of Iholding after capsaicin was an indirect effect of increased glutamate 
release in the synaptic cleft. This idea is also supported by the fact that capsazepine, a 
TRPV1 antagonist, was unable to block the effects of capsaicin. Although our hypothesis 
was not supported by our data, it has led us to a new line of investigation and has provided 
novel insights into the modulation of synaptic transmission by capsaicin.  
Finally, as multiple reports suggest species-related differences in the effects of 
steroid-like molecules and TRP channels modulators, we decided to investigate if the 
effects of alfaxalone and capsaicin on inhibitory and excitatory synaptic transmission to 
HMNs in rats are also replicated in wild type C57/BL6 mice. We show that there is no 
species-related variation in the effect of either alfaxalone or capsaicin. This supports the 
use of alfaxalone anaesthesia in the two most commonly used species in biomedical 
research, provided that neuromotor excitation can be prevented by the use of suitable pre-
medications. 
Our present work on alfaxalone has provided the first evidence that this neuroactive 
steroid selectively reduces inhibitory synaptic transmission to motor neurons. This data 
can be used to design better anaesthetic regimes using alfaxalone, and will particularly 
help in selecting appropriate premedications before alfaxalone anaesthesia in laboratory 
rodents. Similarly, our work on capsaicin has shown for the first time that capsaicin 
significantly modulates synaptic transmission to hypoglossal motor neurons, independent 
from TRPV1 activation, thus broadening our understanding about the pharmacology of 
capsaicin.    
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